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The immune system plays an important role in the regulation of tissue homeostasis ("tissue immune physiology").
Function of distinct tissues during adulthood, including the ovary, requires (1) Renewal from stem cells, (2)
Preservation of tissue-specific cells in a proper differentiated state, which differs among distinct tissues, and (3)
Regulation of tissue quantity. Such morphostasis can be executed by the tissue control system, consisting of
immune system-related components, vascular pericytes, and autonomic innervation. Morphostasis is established
epigenetically, during morphogenetic (developmental) immune adaptation, i.e., during the critical developmental
period. Subsequently, the tissues are maintained in a state of differentiation reached during the adaptation by a
“stop effect” of resident and self renewing monocyte-derived cells. The later normal tissue is programmed to
emerge (e.g., late emergence of ovarian granulosa cells), the earlier its function ceases. Alteration of certain tissue
differentiation during the critical developmental period causes persistent alteration of that tissue function, including
premature ovarian failure (POF) and primary amenorrhea. In fetal and adult human ovaries the ovarian surface
epithelium cells called ovarian stem cells (OSC) are bipotent stem cells for the formation of ovarian germ and
granulosa cells. Recently termed oogonial stem cells are, in reality, not stem but already germ cells which have the
ability to divide. Immune system-related cells and molecules accompany asymmetric division of OSC resulting in
the emergence of secondary germ cells, symmetric division, and migration of secondary germ cells, formation of
new granulosa cells and fetal and adult primordial follicles (follicular renewal), and selection and growth of primary/
preantral, and dominant follicles. The number of selected follicles during each ovarian cycle is determined by
autonomic innervation. Morphostasis is altered with advancing age, due to degenerative changes of the immune
system. This causes cessation of oocyte and follicular renewal at 38 +/-2 years of age due to the lack of formation
of new granulosa cells. Oocytes in primordial follicles persisting after the end of the prime reproductive period
accumulate genetic alterations resulting in an exponentially growing incidence of fetal trisomies and other genetic
abnormalities with advanced maternal age. The secondary germ cells also develop in the OSC cultures derived
from POF and aging ovaries. In vitro conditions are free of immune mechanisms, which prevent neo-oogenesis
in vivo. Such germ cells are capable of differentiating in vitro into functional oocytes. This may provide fresh oocytes
and genetically related children to women lacking the ability to produce their own follicular oocytes. Further study
of "immune physiology" may help us to better understand ovarian physiology and pathology, including ovarian
infertility caused by POF or by a lack of ovarian follicles with functional oocytes in aging ovaries. The observations
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indicating involvement of immunoregulation in physiological neo-oogenesis and follicular renewal from OSC during
the fetal and prime reproductive periods are reviewed as well as immune system and age-independent neo-
oogenesis and oocyte maturation in OSC cultures, perimenopausal alteration of homeostasis causing disorders of
many tissues, and the first OSC culture clinical trial.
Keywords: Fetal neo-oogenesis, Follicular renewal in mammals, Follicular selection, Granulosa cell renewal, Immune
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Available data indicate that the function of distinct tis-
sues, including the ovary, is regulated by so-called mor-
phostasis. Morphostasis is a complex event requiring: 1)
Renewal from stem cells, 2) Preservation of tissue-
specific cells in a proper differentiated state, and 3)
Regulation of tissue quantity. This can be executed by
the tissue control system (TCS) consisting of immune
system-related components, vascular pericytes, and
autonomic innervation. Morphostasis is established epi-
genetically, during morphogenetic developmental im-
mune adaptation, i.e., during the critical developmental
period in embryonic and fetal life. Subsequently, the tis-
sues are maintained in a state of differentiation reached
during the adaptation by a “stop effect” of the resident
monocyte-derived cells (MDC). Alteration of tissue dif-
ferentiation during the critical developmental period
causes persistent alteration of tissue function. Morphosta-
sis is altered with age advancement, due to degenerative
changes of the immune system. Thus ovarian function
ceases and an increased incidence of neoplasia and dege-
nerative diseases occurs with aging (reviewed in [1]).
In this article, the term primordial germ cells is used
to designate the extragonadal germ cells migrating into
gonads during the early embryonic period. The term
secondary, or just germ cells, designates cells originating
from the ovarian stem cells (OSC) in vivo. Ovarian stem
cells are epithelial cells covering ovaries, and were ori-
ginally called “ovarian germinal epithelium” [2,3], then
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cells [7-10]. They are considered to be epithelial in na-
ture, but could originate by mesenchymal-epithelial con-
version from the mesenchymal precursors in ovarian
tunica albuginea (TA) of adult individuals in some spe-
cies, such as humans [11,12].
The primordial follicles can be divided into "fetal
primordial follicles," formed during the second trimester
of intrauterine life from secondary germ cells and emer-
ging granulosa cells, and persisting until the perime-
narcheal period, and "adult primordial follicles," formed
by follicular renewal during the prime reproductive
period (from menarche till 38 +/-2 years of age) and per-
sisting thereafter until menopause.1.1. A concept for the immune system role in the
regulation of ovarian function
Until late 1970', regulation of ovarian function was con-
sidered limited to interactions between the hypothalamo-
pituitary system and the ovary. Such concepts, however,
did not explain a number of experimental data in rats
and mice, such as ovarian "dysgenesis" after neonatal
thymectomy [13-16], prevention of steroid-induced ster-
ility in neonatal rats by thymocytes from fertile females
[17], and superovulation after cyclophosphamide [18]
and x-ray treatment [19].
Our observations indicated that intraperitoneal treat-
ment of adult rats with antithymocyte serum causes ano-
vulation with the persistence of corpora lutea (CL) and a
persisting diestrus [20]. We also found a migration of
immune system-related cells among granulosa cells of
atretic rat follicles [21,22], and a delayed ovarian matu-
ration and shortened reproductive period in nude mice
with congenital absence of the thymus [23].
In 1979, we were the first who proposed a role for the
immune system in ovarian function [24], as recently
noted by Joy Pate et al. [25]. We proposed that ovarian
structures present during the fetal adaptive period of im-
mune system development, such as primordial follicles,
are tolerated by the immune system during adulthood,
while those structures which were absent, such as antral
follicles and CL, have a limited functional life unless
pregnancy occurs. Under normal conditions, the antral
follicles and CL should be cyclically destroyed in order
to maintain the cyclic character of ovarian function. A
lack of atresia of aged antral follicles results in their per-
sistence and the polycystic ovary syndrome. In species
with cyclic ovarian function, the length of the ovarian
cycle (about four days in the rats and mice and 28 days
in humans) is determined by the length of the immune
cycle. We also proposed that age-dependent impairment
of ovarian function is caused by the age-dependent im-
pairment of the immune system [24]. In reality, theimpairment of immune system function with age is the
first in the body, and that of the ovary follows.
In 1980, Espey hypothesized that ovulation of ovarian
follicles involves an inflammatory reaction [26]. The
connective tissue layers of the TA and theca externa
must be weakened to allow the follicle wall to dissociate
and break open under a modest intrafollicular pressure.
Such changes are probably caused by thecal fibroblasts
transformed into proliferating cells similar to tissue
responses to inflammatory reactions [27].
1.2. Developmental immune adaptation and development
of immune tolerance
Developmental immune adaptation represents a stage of
immune system development during which antigens
which are present are tolerated after system immuno-
competence, and those which are absent underwent im-
mune rejection. In humans, the developmental immune
adaptation is terminated after the second trimester and
in small laboratory rodents, it ends after the 7th day of
postnatal life [28].
2. Immune system and tissue homeostasis (tissue
immune physiology)
During the last three decades, the participation of the
immune system in regulation of proliferation, differen-
tiation, and aging of tissue-specific cells in various epi-
thelial, parenchymal, and muscle tissues has gained
increasing interest [1,29-42].
Ninety years ago, Alexis Carrel demonstrated that,
similarly to embryonic tissue extracts, leukocyte extracts
also stimulate multiplication of fibroblasts in vitro, and
suggested that leukocytes bring growth-activating sub-
stances to tissue-specific cells [43]. Later in the 1960s
and 1970s, lymphocytes were shown to promote tissue
growth and regeneration (reviewed in [44]). It has been
suggested that participation in host immune responses is
only one of the many functions of lymphocytes, since
lymphoid cells also participate in a number of physio-
logical processes of homeostasis [44]. While a lot of
work has been done on the role of various growth fac-
tors and cytokines produced by mesenchymal cells on
the cell cycle and death in vitro [45-58], still little is
known about the interactions between mesenchymal and
tissue-specific cells in vivo. The role of immune system
components in the regulation of tissue physiology and
pathology should also be viewed more widely, along with
resident mesenchymal cells, such as fibroblast-derived
vascular pericytes, and autonomic neural signals.
2.1. The tissue control system theory
Our studies in the late 1970s [23,24,59,60] and 1980s
[61,62] resulted in the proposal of a wider role of the im-
mune system (immune cells and vascular pericytes), the
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ovarian function [29]. The TCS theory was further
refined when the role of autonomic innervation in the
regulation of "quantitative aspects in tissues," including
follicular selection, was added [63,64], and the TCS
theory was revised [65,66]. More recently, a role for
the immune system in the regulation of ovarian aging
and the regulation of asymmetric cell division have
been described [37,67,68]. In addition, we proposed a
role of the TCS in immune maintenance of self related
to tissue morphostasis, tumor growth, and regenerative
medicine - reviewed in [1,69-72].
3. Immune system and in vivo regulation of
ovarian function
Ovarian compartments are among those structures show-
ing the most pronounced morphological (cellular prolif-
eration, differentiation, and regression) and functional
changes in the body. Regulation of ovarian function is
complex, involving interactions between follicular com-
partments (oocyte, granulosa, and theca cells), as well as
of sex steroids produced by follicles, CL, and interstitial
tissues originating from theca of degenerating follicles.
Additionally, communication of the hypothalamo-pituitary
system and the influence of gonadotropins, autonomic in-
nervation, growth factors, and cytokines produced by
mesenchymal cells of the immune system all regulate
functions of ovarian compartments. While gonadotropins
are essential for follicular maturation and ovulation [73],
autonomic innervation is necessary for regulation of fol-
licular selection [74,75]. Interactions between the immune
system and ovary are numerous, as immune cells are asso-
ciated with regulation at every level of the hypothalamo-
pituitary-ovarian axis, regulating growth and regression of
both follicles and CL [76,77].
Ovulatory ovarian function during adulthood requires
the presence of oocytes, the origin of which in higher
vertebrates remains uncertain.
3.1. Comparison of the oocyte "storage" and "continued
formation" theories
The origin of germ cells in adult females of higher verte-
brates (birds and mammals) has been a matter of dispute
more than one hundred years. There are, in principle,
two views: the oocyte "storage" and "continued forma-
tion" theories [78].
The "storage" doctrine is based on the belief that there
is never any increase in the number of oocytes beyond
those differentiating during fetal or perinatal ovarian de-
velopment from embryonic (primordial) germ cells [79].
This prevailing dogma was enhanced by the assumption
that the process of oogenesis in animals follows a uni-
form pattern, with two main variants. One variant is that
the oogenesis continues either uninterruptedly orcyclically throughout reproductive life, e.g., most tele-
osts, all amphibians, most reptiles, and possibly a few
mammals. The other variant is that the oogenesis occurs
only in fetal gonads, and oogonia neither persist nor di-
vide mitotically during sexual maturity - for instance in
cyclostomes, elasmobranchs, a few teleosts, perhaps
some reptiles, all birds, monotremes, and with a few
exceptions, all eutherian mammals [80-82].
The advantage of the "storage" theory is that it is easy
to understand: The extragonadal primordial germ cells
migrate into developing ovaries, achieve sex-specific
properties, multiply, and complete meiotic prophase of
oocytes, which form primordial follicles serving a repro-
ductive function up to menopause in humans.
The essential disadvantage is the requirement for sto-
rage of female gametes for up to several decades prior to
utilization. Under such conditions, there is a higher
probability of genetic alterations in stored oocytes due
to the long influence of environmental and other
hazards. On the other hand, the "storage" doctrine sup-
ports evidence in invertebrates and lower vertebrates
that oogenesis continues throughout reproductive life.
What is the advantage of oocyte storage in higher verte-
brates from the Darwinian evolutionary theory point of
view on the development of animal species toward
higher and more adaptive forms of life and reproduction,
e.g., frogs vs. mammals?
The "continued formation" theory proposes that pri-
mordial germ cells degenerate and new oocytes form
during adulthood cyclically from the OSC [78,83], and
that new oocytes are formed throughout life, and in
phase with the reproductive cycle, from germinal epithe-
lium (i.e. OSC) of the adult mammal, at the same time
as vast numbers of already-formed oocytes are elimi-
nated through atresia [3].
The advantage of the "continued formation" theory is
that it defines a uniform capability of oocyte and follicu-
lar renewal in all adult females throughout all species,
making this doctrine acceptable from the evolutionary
insight. The disadvantage is that it is not easy to define a
distinct pattern of this process between the species, for
instance the apparent formation of new oogonia in adult
prosimian primates [84-86], vs. a more cryptic process
in adult humans [11,87].
3.1.1. The prime reproductive period theory
We attempted to establish harmony between the storage
(lack of follicular renewal) and continued formation
(presence of follicular renewal) theories by proposing
the "Prime reproductive period" theory [88]. According
to the "Prime reproductive period" theory, the "storage"
doctrine fits two periods of the life in humans, that be-
tween the termination of fetal formation of new primor-
dial follicles and the advanced puberty or premenarcheal
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are not renewed), and that following the end of the
prime reproductive period at 38+/-2 years of age (ter-
mination of follicular renewal), until the menopause. On
the other hand, the "continued formation" doctrine
accounts for the follicular renewal during the prime re-
productive period, which ensures the availability of fresh
oocytes for healthy progeny. During the prime repro-
ductive period, the number of primordial follicles does
not show a significant decline in human [89] and mouse
females [90] due to the replacement of aging primordial
follicles by follicular renewal [11,87,91]. In adult ovaries,
50-70% of primordial follicles exhibit degenerative changes
[92]. Atresia of primordial follicles declines during the pre-
menopausal period [93], allowing a significantly reduced
number of persisting primordial follicles to remain func-
tional in humans for another 10–12 years, after the ter-
mination of the follicular renewal. While there are no
consequences of oocyte aging for the progeny during
childhood, the oocytes persisting after termination of the
prime reproductive period accumulate genetic alterations
resulting in an exponentially increasing number of fetal
trisomies and other genetic abnormalities with advanced
maternal age (Figure 1; reviewed in [11]).
3.2. A reversal of the oocyte storage to the continued
oocyte formation theory and new perspectives in the
treatment of POF and ovarian infertility caused by a lack
of ovarian follicles with functional oocytes
The oocyte storage theory, developed in the middle of
the last century, remained unaffected until 1990'.Figure 1 The prime reproductive period doctrine. The incidence of tris
age, i.e., after the termination of follicular renewal during the prime reprod
follicle numbers due to their cyclic atresia and renewal during the prime re
M, menarche; AMA, advanced maternal age. Adapted from [94] with permiHowever, in 1995, it was shown that, similarly to adult
mice [78] and prosimians [95], ovarian follicular renewal
exists in adult human females [87]. In functional adult
human ovaries certain segments of OSC descend into
the ovarian stroma and fragment into individual small
granulosa cell nests. In other OSC segments germ-like
cells were detected, and they migrated into the ovarian
stroma, associated with the microvasculature, and even-
tually aggregated with granulosa cell nests. Hence OSC
may be involved in the formation of new primordial fol-
licles in adult human ovaries [87].
The human ovarian study was expanded in 2004 [11],
by showing that OSC in adult human ovaries originate
from ovarian TA, which is formed perinatally by a me-
senchymal transformation of the fetal OSC. In contrast
to males, adult human female gonads do not preserve
fetal germ line stem cells. Differentiation of OSC con-
verted into primitive granulosa and germ cells from the
bipotent mesenchymal cell precursors of TA in adult
human ovaries represents a sophisticated adaptive me-
chanism created during the evolution of female reproduction.
It has also been shown that the number of new adult
primordial follicles is not determined by the number of
new germ cells emerging cyclically during the periovula-
tory periods of the prime reproductive period, but by the
number of available granulosa cell nests. The superfluous
intravascular germ cells increase to the oocyte size and die
in the medullary vessels. This suggests that transplantation
of germ cells into human ovaries lacking granulosa cell
nests will cause their death and not formation of new
adult primordial follicles. Collectively, the data indicatedomic fetuses (dotted line) exponentially increases after 38+2 years of
uctive period (PRP). White line indicates fluctuation of primordial
productive period. PF, primordial follicles; N, neonate; CH, childhood;
ssion, © Informa Healthcare, London, UK.
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does not represent a static but a dynamic population of
differentiating and regressing structures. An essential mis-
sion of such follicular turnover may be elimination of
spontaneous or environmentally induced genetic altera-
tions of oocytes in resting primordial follicles due to the
termination of the follicular renewal [11].
In addition, the study in 2005 [7] for the first time
demonstrated that cultured OSC exhibit neo-oogenesis
in vitro. The neo-oogenesis was detected regardless of
the advanced patient's age or existing premature ovarian
failure (POF), except for the ovaries not exhibiting
in vivo a presence of the OSC [94]. The fertilization of
in vitro developed mature oocytes requires intracytoplas-
mic sperm injection, since the in vitro developed eggs do
not express surface zona pellucida proteins - (see Chap-
ter 10.4.1. below), required for sperm affinity [96]. It has
been shown that intracytoplasmic sperm injection into
zona-free human oocytes results in normal fertilization
and blastocyst development [97] and oocyte morphology
does not affect fertilization rate, embryo quality and im-
plantation rate after intracytoplasmic sperm injection
[98]. Moreover, in vitro developing oocytes may utilize a
phylogenetically ancient mechanism, known from Dros-
ophila ovaries [99]. They divide in order to produce se-
veral satellite (nurse) cells, which are exploited to
provide additional organelles (see Chapter 10.4.1. below)
required for the oocyte growth, that are in vivo provided
by granulosa cells injecting the ooplasm and forming a
Balbiani body [11].
In another 2005 article [100] it was shown that in mid-
pregnancy human fetal ovaries, the granulosa and sec-
ondary germ cells also develop from the OSC and
contribute to the formation of fetal primordial follicles.
Neo-oogenesis in adult mice, described in 1920' and
1930' [78,101], was in 2004 confirmed by another group
of investigators using several lines of evidence [91].
The authors argued that the fetal germline stem cells
do not disappear at birth but persist in adult mouse
ovaries [91].
In 2009, it was shown that isolated mouse germline
stem cells transplanted into ovaries of infertile mice
developed into mature oocytes in antral follicles and
produced offspring [102] (see Chapters 11 and Chapter
13. for more details).
Finally, in 2012, germline stem cells purified from
functional adult human ovaries were shown to produce
new primordial follicles when injected into functional
human ovarian tissue and transplanted into immuno-
deficient mice [103] (see also Chapter 11.). The study
is important, since it is the first direct confirmation of
our report from 1995 that functional adult human
ovaries contain germ cells and exhibit follicular re-
newal [87].Collectively, the above reports published from 1995
until now, clearly demonstrate that neo-oogenesis and
follicular renewal exist in adult mammalian females with
functional ovaries, including humans [104]. It remains to
be determined whether ovaries of reproductive-aged
women with terminated follicular renewal after the
prime reproductive period and ovaries of women with
POF also carry germline stem cells, and if so, whether
such cells can produce new primordial follicles in their
ovaries lacking granulosa cells.
In our opinion, adult mammalian ovaries do not pre-
serve fetal germline stem cells but are capable of produ-
cing germ cells by the asymmetric division of OSC (see
Chapter 4.2.5.). The only conceivable way to enable
women with ovarian infertility to have their own off-
spring is to collect ovarian tissue and establish a culture
of OSC with ovarian stromal cells substituting for granu-
losa cells. The in vitro developed mature eggs (see Chap-
ter 10) can be fertilized [94], with subsequent ART
management of the collected embryos. This approach
can not be used in women lacking in vivo OSC or TA
precursors in their ovaries (see Chapter 10.7.).
3.3. Primordial germ cells
It is now well known that mammalian primordial germ
cells originate from uncommitted (totipotent) somatic
stem cells, known as embryonic stem cells (ESC) in the
inner cell mass of the blastocyst expressing STELLAR
and deleted azoospermia-like (DAZL) proteins of human
germ cells, oocytes, and ESC [105,106]. The sex com-
mitment of germ cells is determined by local gonadal
environment - signals produced by neighboring somatic
cells [107]. Studies of mouse embryos, in which genetically
marked cells were introduced at the 4- and 8-cell stage
blastomere, have shown that such cells can either become
germ or somatic cells [108]. This suggests that no specific
germ cell commitment exists prior to implantation. Du-
ring the postimplantation period, mouse germ cells are
not identifiable before seven days after fertilization [109],
suggesting that germ cells differentiate from somatic
lineage [110]. It has also been shown that cellular differen-
tiation of grafted embryonic cells does not depend on
where the grafts were taken, but rather where they are
placed [111].
After primordial germ cells enter the developing em-
bryonic gonad, they commit to a developmental pathway
that will lead them to become either eggs or sperm, de-
pending not on their own sex chromosome constitution
but on whether the gonad has begun to develop into an
ovary or a testis. The sex chromosomes in the gonadal
somatic cells determine which type of the gonad will
develop, as a single Sry gene on the Y chromosome can
redirect a female embryo to become a male (reviewed
in [107]).
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mechanisms of oocyte formation
4.1. Human embryonic ovaries
Ovarian differentiation begins before follicles form. It is
characterized by the evolution of the OSC from coe-
lomic (peritoneal) mesothelium in the region of the go-
nadal ridge, organization of the rete ovarii developing
from mesonephric ducts, and development of oocytes
from germ cells. In human embryos, primordial germ
cells arise outside the urogenital ridge, in the dorsal
endoderm of the yolk sac at 24 days of developmental
age. They migrate by ameboid movements into indiffer-
ent gonadal primordial tissue at 28–35 days [112]. After
reaching the urogenital ridge, the primordial germ cells
expressing VASA, a protein which is required for germ
cell maintenance and function, and initially accumulate
among OSC of the developing gonads [113]. Differen-
tiation of an indifferent gonad into an ovary or a testis
takes place during the second month [114]. At the age
of nine weeks, female gonads show a marked develop-
ment of rete cords with lumen formation. The rete
reaches the center of the ovary at 12 weeks, when mei-
osis of oocytes begins. The nuclei of the germ cells lie
close together in clusters without clearly defined cell
membranes. These syncytia are surrounded by slender
stromal (mesenchymal) cells [112].
4.2. Human fetal ovaries
Developing fetal ovaries are filled with numerous germ
cells and maturing oocytes expressing VASA at 15 weeks
of age, but at the same age the developing testes contain
only scattered VASA positive germ cells in seminiferous
tubules [113]. Numerous germ cells 10 micrometers in
diameter are present in human fetal OSC, and they often
exhibit a tadpole-like shape, suggesting their ability to
migrate [115,116].
The first primordial follicles are formed in the human
fetus after month four. This is substantially latter than
the early embryonic occurrence of primordial germ cells.
The delayed appearance of primordial follicles may be
caused by a requirement for activated MDC with forma-
tion of primitive granulosa cells from bipotent OSC and
also association of activated MDC with a formation of
primordial follicles (see below). Activated MDC are
detected in the second trimester human fetuses [117].
Follicle formation always begins in the innermost part
of the cortex, close to the rete ovarii, which is essential
for follicular development. Follicles will not form if it is
removed before formation of primordial follicles has
started [118]. Formation of the follicle requires attach-
ment of granulosa cells to the oocyte surface and closure
of the basement membrane around this unit. At five
months of fetal age, the ovary contains its peak popula-
tion of oocytes. In human fetal ovaries at thedevelopmental age 5.5 months, newly differentiated oo-
gonia are found to lie within and just bellow the OSC
(plate 17C in Ref. [119]). At seven months of intrauter-
ine life the last oogonia enter meiosis (reviewed in
[112]).
4.2.1. Origin of secondary germ cells and granulosa cells
from fetal ovarian stem cells
The OSC have been implicated in the formation of
oocytes in mice and humans [2,3,11,78,87,100,114,120],
and it also has been suggested that the OSC are a source
of granulosa cells in fetal and adult mammalian ovaries
[11,87,115,121-123]. The formation of germ cells from
OSC is, however, a selective process. In a given time,
only some OSC are transformed into germ cells [87].
Figures 2, 3, 4 show morphological and immunohisto-
chemical observations in midpregnancy human fetal
ovaries. The germ cells within OSC are smaller (white
arrowheads, Figure 2A; PAP staining) when compared to
oocytes positioned deeper in the cortex (black arrow-
head). Oocytes with well-defined cytoplasm (black
arrowhead) lie among smaller cells with round or elon-
gated nuclei (black arrow). Beneath the well-defined
germ cells lies a nuclear cluster (nc) or syncytium of
germ cells, and the entire area is surrounded by mesen-
chymal cell cords (mcc), i.e., extension of the rete cords
into the cortex.
Figures 2B-E show fetal primordial follicles and asso-
ciated mesenchymal cells. In the innermost part of the
cortex follicles (asterisk, Figure 2B) develop in close
vicinity to the microvasculature (v). Note the strong
major histocompatibility heavy chain class I antigens
(MHC-I) expression by endothelial cells and moderate
expression by granulosa cells. Figure 2C shows secretion
of Thy-1+ intercellular vesicles (arrow) from vascular
pericytes (v) to the fetal primordial follicle (asterisk). An
arrow in Figure 2D demonstrates the large activated
MDC (HLA-DR+) associated with a growing primary fol-
licle (asterisk). Figure 2E shows moderate cytokeratin
(CK) expression by granulosa cells (arrow).
4.2.2. Rete ovarii channels contain immune system-related
cells
Figures 2F-L show the rete at the center of the fetal
ovary. Staining with H&E (Figure 2F) shows the loose
character of the rete, containing spacious lumina or rete
channels (rc). Cells forming the rete ovarii do not ex-
press CK (Figure 2G), but do express Thy-1 differen-
tiation protein, and the strongest Thy-1 expression is
characteristic of pericytes accompanying rete vessels
(v, Figure 2H). The rete ovarii also contains CD14+
(primitive) small MDC (Figure 2I) differentiating into
large activated [class II major histocompatibility anti-











































25 µm 10 µm
Figure 2 The human fetal ovary (24 weeks). Papanicolaou (PAP) staining and immunohistochemistry as indicated in panels. A) Secondary
germ cells descend (white arrowheads) from the OSC between mesenchymal cell cords (mcc), enlarge within the cortex (black arrowhead) above
the nuclear cluster (nc) or syncytium of germ cells. The arrow indicates a mesenchymal type cell. Expression of MHC class I (B), Thy-1 (C), DR of
activated MDC (D), and cytokeratin (CK) accompany primordial and primary follicles (asterisks) and vessels (v). F) H&E staining of rete ovarii
showing rete channels (rc). The rete shows no CK expression (G) but show high Thy-1 staining (H). The presence of CD14+ primitive MDC (I), DR
+ MDC (J) and CD3 (K) and CD8 T cells (L). M) Numerous oocytes exhibit degenerative changes (vacuolization). A scale bar in (L) for panels A-L.
See text for details. Adapted in part from [100] with permission, © Humana Press.
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(arrowhead) with resident MDC (r). In addition, T
cells expressing CD3 (Figure 2K) or CD8 (Figure 2L)
of cytotoxic/suppressor T cells are also present in the
rete channels.
4.2.3. Degeneration of fetal oocytes
Many germ cells and oocytes within the developing
ovary degenerate [112]. The maximum of oocytes in
human fetal ovaries (5–7 millions) is present in the sixth
fetal month, and they are reduced to one million birth
birth. Figure 2M shows a degenerating oocyte (asterisk)
accompanied by an irregular layer of granulosa cells.
Note extensive oocyte cytoplasmic vacuolization.
4.2.4. Origin of primitive granulosa cells
Sprouts of primitive granulosa cells (pgc, Figure 3A) ori-
ginate from the OSC which migrate into the ovary. Indi-
vidual sprouts of granulosa cells are surrounded by
mesenchymal cell cords (mcc), and primitive granulosa
cells show a decrease in CK expression compared to
OSC (osc, Figure 3A). Primitive granulosa cells associate
with available oocytes (asterisk, Figure 3B) to form fetalprimordial follicles. Pericytes accompanying microvascu-
lature in mesenchymal cell cords release large quantities
of Thy-1+ intercellular vesicles (arrows, Figure 3C),
which then migrate between adjacent oocytes and primi-
tive granulosa cells. These intercellular vesicles collapse
into the characteristic empty "spike-like" structures
(arrowhead, Figure 3C) after reaching their targets, indi-
cating release of their vesicular content.
Rete cords (rc, Figure 3D and E; rete extensions) con-
sisting of mesenchymal cells, underlie segments of the
OSC. Pericytes adjacent to the OSC secrete Thy-1+ ma-
terial among OSC. This material consists of intercellular
vesicles (arrowheads, Figure 3D and E) converted into
empty "spikes" (arrows).
4.2.5. Secondary germ cells originate by asymmetric
division of ovarian stem cells
Some cells within the OSC show asymmetric division
(white arrowheads, Figure 3F and G) accompanied by a
diminution of MHC-I and light chain (beta2m) expres-
sion in one of the daughter cells (black vs. white aste-
risks, Figure 3F and G). The size of these cells





































Figure 3 The human fetal ovary (24 weeks). A) Sprouts of primitive granulosa cells (pgc) originating from OSC between adjacent
mesenchymal cell cords. B) In the cortex the primitive granulosa cells associate with available oocytes (asterisk). C) Pericytes (white arrow) in
mesenchymal cell cords release large quantities of Thy-1 (black arrows and arrowhead) among adjacent oocytes and primitive granulosa cells.
D and E) Rete cord (rc) extensions underline OSC and secrete Thy-1 (arrowheads) collapsing into spikes (arrows). F and G) Secondary germ cells
(black asterisks) originating by asymmetric division of OSC (white asterisks) show depletion of MHC heavy (F) and light chain (G). Staining as
indicated in panels (see Figure 2 legend). G) beta 2 microglobulin (beta 2m) = MHC class I light chain. Asterisks indicate germ cells/oocytes.
Abbreviations and arrows/arrowheads are explained in the text. Adapted in part from [100] with permission, © Humana Press.
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quently divide symmetrically (black arrowhead and black
asterisks, Figure 3G).
4.2.6. Monocyte-derived cells and T cells accompany origin
of secondary germ cells
Why are only some OSC transformed into germ cells? It
has been suggested that to become a germ cell, the OSC
receive an impulse from ovary-committed bone marrow
cells, such as monocytes and T cells, in a milieu of favor-
able systemic (hormonal) conditions ([100] and Table 1).
During ovarian development the immune system-related
cells migrate through the rete ovarii and interact with
resident MDC (Figure 2I-L), and this may result in their
ovarian commitment.
In the upper cortex adjacent to the OSC, primitive
CD14+ MDC exhibit extensions among some OSC(arrowheads, Figure 4A), and accompany (arrowheads,
Figure 4B) the symmetric division of germ cells (asterisks).
Activated MDC exhibit the morphology of mature den-
dritic cells (DC) (Figure 4C). Focal HLA-DR staining is
seen among OSC (Figure 4D), suggesting that DC may
undergo apoptosis similar to that observed in the normal
stratified epithelia of adults [125,126] and/or some OSC
may express HLA-DR when activated. Strong binding of
Ig-kappa (most probably fetal IgM) is apparent in OSC
but not the germ cells (asterisk, Figure 4E). T cells migrat-
ing through the rete channels and cords associate (arrow-
head, Figure 4F) with the emerging germ cells (black vs. a
white asterisk) and exhibit an activation (HLA-DR expres-
sion) pattern (Figure 4G). The association of MDC and T
lymphocytes with the OSC suggest that they are ovary-
committed, possibly occurring during their migration
































Figure 4 The human fetal ovary (24 weeks). CD14+ MDC (m, A) exhibit extensions (arrowheads) among some OSC, and accompany
(B) symmetrically dividing (arrowheads) secondary germ cells. C and D) Germ cells (black asterisks) originating by asymmetric division from OSC
(white asterisks) are accompanied by DR+ MDC (m), and also by CD8+ (F) and DR+ (G) T cells. E) Ig kappa light chain of immunoglobulins (Ig-kappa) is
depleted in emerging germ cells. Adapted in part from [100] with permission, © Humana Press.
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is a process driven by ovary-committed bone marrow
cells. The number of ovary-committed bone marrow
cells interacting with the OSC may determine the num-
ber of germ cells actually originating in the ovaries.
High binding of immunoglobulins to OSC may prevent
them from spontaneous (not driven by ovary-
committed bone marrow cells) transformation into
germ cells. Heat-inactivated serum in media of OSC
cultures lacks immunoglobulins, and, therefore, the
OSC proliferate and differentiate into oocytes withoutTable 1 Working model of age-associated changes of
ovary-committed bone marrow cells (OC-BMC) and
hormonal signals (LH/hCG & E2) required for the
initiation & resumption of oogenesis in human ovaries
Period of life OC-BMC3 LH/hCG4 E25 Oogenesis
First trimester - midpregnancy yes yes yes yes6
Last trimester - newborn yes no yes no6
Postnatal - menarche yes no no no7
The prime reproductive period1 yes yes yes yes6
Premenopause2 no yes yes no7
Postmenopause no yes no no6
1 From menarche till 38 +/-2 years of age.
2 From 38+/-2 years till menopause.
3 MDC & T cells with commitment for stimulation of OSC to germ cell
transformation.
4 Levels corresponding to the mid cycle LH peak, or more (hCG levels should
be 10x more, since it has only a 10% affinity to the LH receptor compared to
that of LH - see Ref. [124]).
5 Levels corresponding to the preovulatory E2 peak, or more.
6 Confirmed.
7 Predicted.
Adapted from [100] with permission, © Humana Press Inc.the need of the presence of MDC and T cells (see
Chapter 10).
In contrast to the association of T cells with the origin
of OSC-derived secondary germ cells in vivo, T cells
were not found accompanying (i.e., to be required for)
follicular growth. Both processes were accompanied by
activation of Thy-1+ pericytes and association of MDC,
however.
4.2.7. Conclusions on the origin of secondary germ cells
These observations indicate that secondary germ cells
originate by asymmetric division of the OSC. This is
quite complex, since it requires a sequential involvement
of the immune system and TCS related cells and mole-
cules. This includes the involvement of primitive MDC,
activation of Thy-1+ vascular pericytes, the interaction
of activated (HLA-DR+) MDC, and involvement of acti-
vated (HLA-DR+) T cells. Once formed, the germ cells
undergo symmetric division required for crossing over
of chromosomes. Next, they attain the tadpole like
shape, enabling them to leave the OSC and enter the
ovarian cortex, where they differentiate into oocytes.
The oocytes then associate with OSC-derived granulosa
cells to form fetal primordial follicles. Therefore, the
OSC have the dual potential to differentiate either into
somatic granulosa cells or female secondary germ cells,
depending on the local cellular signaling and hormonal
conditions [100].
An interesting question is whether the OSC are com-
mitted toward production of secondary germ cells per
se, once differentiation from peritoneal mesothelium in
developing embryonic gonads begins. Alternatively, such
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primordial germ cells. Although extragonadal primordial
germ cells may degenerate after entering the gonad, they
nevertheless play an important role in gonadal develop-
ment. In the chick, the germ cells are first recognizable
in the crescentic area of the germ-wall endoderm as
early as twenty-four hours of incubation [127]. Reagan
[128] cut out this crescentic area, in which the primor-
dial germ cells were supposedly located. The operated
chicks were then further incubated and killed for exam-
ination after varying lengths of time. In no instance,














Figure 5 Model of OSC commitment for production of secondary ger
week of gestational age, prior to the arrival of primordial germ cells (pgc).
commitment of OSC (c-OSC) for production of secondary germ cells (sgc).
produced from OSC influenced by hormonal signaling and cellular signalin
ovarian cortex and differentiate into definitive oocytes (do). D) All OSC are
influenced by CS undergo asymmetric division (ad) followed by symmetric
secondary germ cells (m-sgc) leave OSC and enter the ovarian cortex. E) O
appears to require primitive (CD14+) MDC (P-MDC), activated pericytes (P)
(A-MDC) and activated (DR+) T cells (T). Adapted from [69] with permissiondid germ cells arise from somatic cells of the gonads,
even after establishment of the OSC. In the normal
chick, the OSC are well formed on the fourth day of
incubation, and the primitive ova are clearly recog-
nizable among them [129]. But in Reagan's operated
chicks, even after five days of incubation, no germ cells
were recognized [128]. These observations indicate that
the production of secondary germ cells from the OSC
require OSC commitment induced by primordial germ
cells.
A proposed model of OSC commitment for the pro-
















m cells. A) The uncommitted OSC (u-OSC) is present during sixth
B) Primordial germ cells invade OSC during seventh week and cause
C) The primordial germ cells degenerate and secondary germ cells are
g (MDC, Thy-1 pericytes, and T cells). The secondary germ cells enter
influenced by systemic hormonal signals (HS), but only those
division (sd) required for crossing over (co). Tadpole-like migrating
rigination of secondary germ cells from OSC by asymmetric division
with a lack of suppressive neural signaling (NS-), activated (DR+) MDC
, © Transworld Research Network.
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cells (u-OSC, Figure 5A) are present in human embryos
during the fourth week of development, prior to arrival
of primordial germ cells. The primordial germ cells (pgc,
Figure 5B) invade the OSC during the fifth week and
commit the OSC (c-OSC) for production of secondary
germ cells. The primordial germ cells degenerate and
secondary germ cells (sgc, Figure 5C) are produced from
OSC influenced by hormonal and cellular signaling.
Hormonal signaling includes estradiol (E2) and hCG,
cellular signaling includes MDC, Thy-1 pericytes, and T
cells. The secondary germ cells enter the ovarian cortex
and differentiate into definitive oocytes (do). All OSC
are influenced by hormonal signaling, but only those
influenced by cellular signals undergo asymmetric di-
vision (ad, Figure 5D) followed by the symmetric di-
vision (sd) required for crossing over (co). Tadpole-like
migrating secondary germ cells (m-sgc) enter the ovarian
cortex.
The involvement of cellular signaling in the origin of
secondary germ cells by asymmetric division of OSC (ad,
Figure 5E) is complicated. It requires primitive and acti-
vated MDC, activated pericytes [(P), with permissive
autonomic neural signaling (NS-), i.e., a lack of neural in-
hibition], and activated T cells (T). The thymus-derived
ovary-committed T cells may eventually diminish with
the age-induced thymic regression. This may be why the
development of new germ cells ceases by the end of the
third decade of life (Figure 1 and Table 1). The symmet-
ric division of germ cells follows (sd, Figure 5E) and
appears to require primitive MDC (see Figure 4B and
below). Migration of secondary germ cells (m-sgc,
Figure 5E) is accompanied by activated MDC, which
contributes HLA-DR to germ cells (see Chapter 6.2).
Another interesting question is why the developing
ovary exhibits so high number of germ cells developing
into oocytes, and why the oocytes enter meiotic pro-
phase at the time when the rete ovarii developing from
mesonephric ducts reaches the center of the ovary. This
contrasts with scarce male gametes and a lack of meiotic
prophase in developing male gonads [130]. An import-
ant aspect for unique meiotic activity of female germ
cells and oocytes appears to be the prevention of meso-
nephric cell migration and testis cord formation in
developing ovaries [131]. Hence, arrest of some oocytes
of developing ovaries in meiotic prophase appears to
help determine ovarian structure preventing the ten-
dency to develop testicular morphology.
Most fetal oocytes are not preserved till adulthood, but
undergo the process of perinatal demise. Nevertheless, it
is possible that fetal differentiation of oocytes and prim-
ordial follicles, not functionally required until at least pu-
berty and during sexual maturity, may play an important
role in programming the time span for the existence ofperiodical follicular renewal during the prime reproduct-
ive period in adulthood [132] (see Chapter 7.).
5. Cessation of oogenesis in prenatal human
ovaries
The origin of new human oocytes and fetal primordial
follicles ceases after the second trimester of fetal intra-
uterine life, possibly due to the diminution of circula-
ting human chorionic gonadotropin in the fetal blood
[100]. Thereafter (perinatally), the layer of loose mesen-
chymal cells forming ovarian TA develops by mesen-
chymal conversion of OSC, exhibiting some features of
the OSC (CK expression), possibly originating from
epithelial-mesenchymal conversion of the OSC [11,12],
as described in OSC cultures [133]. These TA mesen-
chymal cells could be converted back into the OSC by
mesenchymal-epithelial conversion, i.e., into bipotent
stem cells capable of differentiating into granulosa and
secondary germ cells in adult human ovaries [11,87,134].
This, however, may not happen prior to puberty or me-
narche, due to a lack of hormonal signaling (Table 1,
[100]).
6. Oocyte and follicular renewal in humans during
the prime reproductive period
During adulthood, the CK+ fibroblast-like mesenchymal
cells in TA are progenitors of bipotent OSC in humans.
One advantage of mesenchymal cell progenitors is that
they are much more resistant to epigenetic and environ-
mental hazards, compared to highly sensitive oocytes, as
evident from exponentially growing fetal abnormalities
after termination of oocyte and follicular renewal from
OSC (Figure 1).
6.1. Origin of new granulosa and germ cells from
bipotent ovarian stem cells
Follicular renewal in adult human ovaries from bipotent
OSC, i.e. precursors of germ and granulosa cells, is a
two-step process, consisting of the new formation of epi-
thelial cell nests (primitive granulosa cells) and the for-
mation of new germ cells [11].
6.1.1. Origin of new granulosa cells
Similar to fetal ovaries, new granulosa cells develop in
adult human ovaries from the bipotent OSC, but the
process and results are different. In human fetal ovaries,
primitive granulosa cells develop between mesenchymal
cell cords and form in the adjacent cortex solid epithelial
cords, similar to those described in adult rodent ovaries
[3]. These primitive granulosa cells are then available for
an unlimited number of germ cells entering epithelial
cords to form primordial follicles in fetal human ovaries
(see Figure 3A-C) and adult rodent ovaries [135]. The
formation of new primordial follicles in adult human
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association of a single germ cell with a single epithelial
nest of primitive granulosa cells. Since the number of
epithelial granulosa nests formed during the follicular
phase of the each menstrual cycle is lower than the
number of new germ cells formed during the perio-
vulatory periods, excessive germ cells degenerate (see
Chapter 11.3.).
The initiation of granulosa cell nest formation consists
of an extension of TA (ta, Figure 6A) over the ovarian
surface, the so called TA flap (taf arrowhead). F29 indi-
cates the age of the female ovaries which were studied.
This TA flap contains CK+ fibroblast-like cells (+fb,
Figure 6B, detail of TA flap from panel A), which are
converted into OSC precursors (fb/osc) and OSC
(rounded arrow and osc). For the emergence of granu-
losa cells, this process is associated with numerous DR+
MDC (asterisks, Figure 6C) and early OSC show weak
DR expression (arrow). Inset in Figure 6A shows forma-





















Figure 6 Origin of new granulosa cells from OSC during the prime re
ovarian surface and adjacent cortex. Dashed line indicates interface betwee
stem cells; taf and black arrowhead - TA flap; white arrowhead - a lack of O
(A) shows association of CK+ (brown color) fibroblasts (+fb,) with the TA fla
morphology (fb/se), and ovarian stem cells (osc, arched arrow). C) A paralle
Note DR expression also in early OSC (arrow). D) Detail from (A) shows CK+
between the ovarian cortex (ovc) and TA (ta). Note diminution of CK immu
fragmenting into granulosa cell nests (arrowheads in the upper ovarian cor
F) Lower ovarian cortex (lc) with primordial follicles. Arrow indicates distan
inset. F29 indicates female age in years. Bar in (D), for (B-D). Panels A, B, D-F
Liss, Inc. with permission.collapses into a bilaminar OSC cord (white arrow,
Figure 6A) and is overgrown by CK unstained TA (white
arrowhead). Detail of CK+ OSC cord adjacent to the
ovarian cortex (ovc) is shown in Figure 6D. Dashed line
in Figure 6A indicates TA and ovarian cortex interface -
note that the formation of the OSC cord begins on the
ovarian cortex lacking the TA.
An ovary from another female in the prime repro-
ductive period (F28) shows in Figure 6E an upper ovar-
ian cortex (uc) with a fragmentation of OSC cords
(black arrows) into primitive granulosa cell nests
(arrowheads). Figure 6F shows lower ovarian cortex (lc,
close to the ovarian medulla - 1000 micrometers from
the ovarian surface) containing primordial follicles.
Dashed box indicates primordial follicle shown in the
inset. New primitive granulosa cell nests move to this
level during each periovulatory phase in the prime re-
productive period and associate with intravascular or




























productive period in adult human ovaries. A) Panoramic view of
n TA and stroma of the ovarian cortex. osc and black arrow - ovarian
SC above the TA; white arrow -bilaminar epithelial cord. B) Detail from
p surface (arrowhead), transition from mesenchymal to epithelial
l section to (B) showing numerous DR+ MDC (asterisks) in the TA flap.
epithelial cord consisting of two layers of epithelial cells and lying
noexpression in TA fibroblasts (+/-fb). E) Epithelial cords (black arrows)
tex (uc). White arrow CK+ OSC associated with the TA with flap.
ce from the ovarian surface, dashed box indicates follicle shown in the
adapted from [11], © Antonin Bukovsky; panel C from [134], © Wiley-
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For the formation of secondary germ cells in adult
human ovaries during the prime reproductive period,
the single layer of OSC is formed at the ovarian surface
from CK+ TA fibroblasts (Figure 7A) during the perio-
vulatory period. The granulosa cell nests (n, Figure 7B)














































Figure 7 Follicular renewal in adult human ovaries. A) Cytokeratin (CK)
(ta) exhibit mesenchymal-epithelial transition into OSC (osc). Inset shows a
venule (v) in deep ovarian cortex, which extends an arm (a) to catch the o
C) The nest body (n) and closing "gate". A portion of the oocyte (dashed li
(arched arrow). The oocyte contains intraooplasmic CK+ extensions from th
paranuclear (Balbiani) body (asterisk). The oocyte nucleus is indicated by a
oocyte-nest assembly. CK indicates cytokeratin staining of primitive granulo
oocyte. E) Segments of OSC show cytoplasmic PS1 (meiotically expressed c
exhibiting nuclear PS1 (+ nuclei vs. - cell daughters) and descending from
germ cells increase in size, show a symmetric division (black arrow) and ex
entering (white arrow) the upper ovarian cortex (uc). G) Association of prim
boxes indicate unassembled epithelial nests. Inset shows origination of ger
segment (white arrowhead) associated with unstained round cell nucleus (
unstained nucleus (dotted line) and ZP+ staining of the intermediate segm
ZP+ (dark color) degenerating oocytes with unstained nuclei (arrowheads).cortex to catch the circulating oocytes (o) from the
blood. During follicle formation, extensions of granulosa
cells penetrate the ooplasm (arrowheads, Figure 7C) like
a sword in the shield to form a single paranuclear Bal-
biani body (asterisk). It contains additional organelles
which the oocyte needs to develop later into the mature



























positive (brown color) cells of fibroblast type (fb) in tunica albuginea
transitory stage (fb/e). B) The CK+ epithelial nest (n) inside of the
ocyte (o, dashed line) from the blood circulation. e = endothelial cell.
ne) still lies outside of the complex, and is expected to move inside
e nest wall (arrowheads), which contribute to the formation of CK+
dotted line. D) The occupied "bird's" nest type indicates a half way
sa cells and ZP indicates zona pellucida expression in the assembling
arbohydrate) expression. Asymmetric division of OSC gives rise to cells
the OSC into tunica albuginea (ta). F) In tunica albuginea, the putative
hibit development of cytoplasmic PS1 immunoexpression when
ary follicles (arrowhead) with the cortical epithelial crypt (ec). Dashed
m-like cells among CK+ cells (CK) in epithelial crypt. Note ZP+
asterisk). H) Migrating germ cells with tadpole shape (dashed line),
ent (arrowhead). I) Some medullary vessels (v) show accumulation of
Arrow indicates ZP release. Adapted from [11], © Antonin Bukovsky.
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cells (CK, Figure 7D) and zona pellucida (ZP) glycopro-
tein of assembling oocytes [11].
Germ cells originate by asymmetric division of OSC
differentiating above the TA (Figure 7E). The germ cells
showing PS1 meiotically expressed oocyte carbohydrate
antigen [(+) vs. (-) sign] enter the TA, where they
undergo a symmetric division (black arrow, Figure 7F)
required for the crossing over, and then enter (white
arrow) the adjacent upper cortex (uc) and cortical ves-
sels. During vascular transport the germ cells increase in
size, and are picked up by epithelial nests (see above
panel B).
An alternative origin of germ cells in human ovaries is
by OSC crypts originating from OSC invaginations into
the deep cortex. Such epithelial crypts (ec, Figure 7G)
show transformation of OSC into ZP+ (arrowhead in
inset, Figure 7G) germ cells (asterisk), which are capable




















Figure 8 Immune type cells influence commitment of OSC. Staining of
cortex (ct) for CD14 of primitive MDC and HLA-DR of activated MDC, CD8
glycoprotein of pericytes, as indicated in panels. Large asterisks and dashed
OSC (arrows) and accompany (arrowheads) origination of germ cells by asy
accompanied by extensions from T cell (arrowheads) into a putative germ
symmetric division (s-s') of germ cells in tunica albuginea and their migrati
are accompanied by activated MDC (open arrow), and HLA-DR material is a
(arrowhead). E) The germ cells associate with cortical vasculature (cv) stron
by the bloodstream (F). Adapted from [87], with permission, © Blackwell Pucells (dashed boxes, Figure 7G) to form new primordial
follicles (arrowhead). Hence, even if the OSC is not
available (or is destroyed) the cortical epithelial crypts
are an alternative source of germ cells. For formation of
adult primordial follicles, however, the nests of primitive
granulosa cells should be available. When the epithelial
nests are not available locally, the ZP+ tadpole-like germ
cells resembling sperm (Figure 7H) migrate to attain
cortical vessels and utilize vascular transport to reach
distant targets (see Figure 7B). Finally, the intravascular
oocytes, which were not utilized in the formation of
adult primordial follicles, degenerate (arrowheads,
Figure 7I) in the medullary vessels (v).
6.2. Involvement of the immune system-related cells
Like in fetal ovaries, the ovary-committed bone marrow
cells are associated with oogenesis in adult human ova-
ries [87]. CD14 primitive MDC interact with OSC


















the adult human OSC (osc), tunica albuginea (ta), and an adjacent
of cytotoxic/suppressor T cells, MHC class I heavy chain, and Thy-1
lines indicate putative germ cells. A) Primitive MDC associate with
mmetric division of OSC (asterisks). B) Asymmetric division is also
cell daughter. C) Primitive MDC accompany (white arrowheads)
on into the adjacent cortex (ct). D) Migrating tadpole-like germ cells
pparent in the cytoplasm (solid arrow) and in the nuclear envelope
gly expressing MHC-I (arrows vs. arrowhead), enter and are transported
blishing, Oxford, UK.
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http://www.rbej.com/content/10/1/97(white and black arrowheads) - note small cell size of
the OSC stem cell daughter (yellow asterisk) compared
to the secondary germ cell daughter (black asterisk).
CD8+ T cells accompany germ cells through asymmetric
division of OSC (arrowheads, Figure 8B). Primitive
MDC (m, Figure 8C) are also associated with symmetric
division of germ cells (white arrowheads, Figure 8C) in
TA and with germ cells entering (black arrowhead) the
upper cortex (ct). Activated MDC are associated
(arrow, Figure 8D) with migrating germ cells, and these
cells associate (arrow, Figure 8E) with the cortical vascu-
lature (cv) and utilize (arrowhead and asterisk,
Figure 8F) vascular transportation (arrow) to reach dis-
tant destinations.
6.3. Localization of SCP3 in adult human and monkey
ovaries
In a study by Liu et al. [137] the authors compared the
expression of meiotic entry synaptonemal complex
protein-3 (SCP3) in fetal and in functionally undefined
adult human ovaries. The authors argued that SCP3 pro-
tein was not detectable in the TA, OSC, or in oocytes of
adult primordial follicles in adult human ovaries, and
concluded that no meiotic oocytes are present in ovaries
during adulthood. In a subsequent commentary, Tilly
and Johnson [138] stated that the lack of evidence in
this study of neo-oogenesis in adult human females is
not convincing, and that some data of Liu et al. [137]
actually support the existence of neo-oogenesis in adult
women.
We studied SCP3 expression using the same SCP3
antibody, and found the immunoreactivity with seg-
ments of TA, OSC, and in oocytes of one third of adult
primordial follicles in functional midcycle adult human
and monkey ovaries [139]. Functional ovaries without
evidence of ongoing follicular renewal (midfollicular,
mid- and late luteal phases) indeed lacked staining for
SCP3 in TA, OSC, and in adult primordial follicles.
Functional ovaries with ongoing follicular renewal, i.e.,
with unoccupied nests of primitive granulosa cells (often
occupying a portion of the vascular lumen), oocyte/nest
assemblies, and degenerating superfluous oocytes in
ovarian medullary vessels (see Figure 7I), were observed
during the postovulatory (early luteal) phase of the men-
strual cycle. In these ovaries a strong SCP3 expression
was shown in some segments of TA. Such TA cells
exhibited a mesenchymal pattern, characteristic of the
OSC precursors. The differentiated OSC layer also
showed SCP3 immunostaining. SCP3 immunoexpression
was also evident in differentiated OSC of postovulatory
monkey ovaries.
Moreover, the SCP3 immunostaining was observed in
the nucleoli of oocytes in some adult primordial follicles
in human and monkey ovaries. Laura L. Tres hasreported that male germ cells exhibit nucleolar SCP3 ex-
pression during early stages of meiotic prophase [140].
In addition, an SCP3+ synapsis of two chromosomes
was detected in human primordial follicle oocyte, pos-
sibly representing XX chromosomal synapsis, since sex
chromosomes start synapsis during early zygotene, be-
fore autosomes synapse [140]. Rare SCP3+ oocytes (less
then 10%) were detected in midfollicular phase ovaries.
The most frequent expression (10 to 30% of primordial
follicle oocytes) was found in postovulatory ovaries du-
ring the early luteal phase in younger (till 38 years of
age) women. However, at the age of 42 years, postovula-
tory ovaries showed no SCP3 expression.
No staining of oocytes was observed in three younger
women studied during the mid- and late luteal phases
and in PCO ovaries [139]. SCP3 expression was also
reported in juvenile and adult mouse ovaries [102].
These observations indicate that SCP3 is expressed in
adult human, monkey, and mouse ovaries. SCP3 expres-
sion detected in TA stem cells indicates that preparation
for meiotic activity may have already occurred at the
level of TA OSC progenitors, and meiotic prophase ac-
tivity may continue and terminate in the oocytes of
newly formed adult primordial follicles. SCP3 expression
in about 30% of primordial human follicles during fol-
licular renewal indicates that during each menstrual
cycle about 30% of adult primordial follicles are
replaced. These data also confirm that follicular renewal
occurs during the prime reproductive period, but not
thereafter, and is not present in PCO ovaries.
6.4. Summary on follicular renewal in adult human
ovaries
The origin of new epithelial nests and germ cells and
their assembly in adult human ovaries is schematically
depicted in Figure 9. Under the influence of cellular and
other local signaling (CS & LS, Figure 9A), including im-
mune system-related activated MDC [134] and neural
signals and molecules [87], the TA overgrows the upper
ovarian cortex (uc, Figure 9A) and its mesenchymal cells
attain CK expression and transform into OSC. In this
way, the bilaminar OSC layer is formed, which descends
into the cortex (arrow), and fragments into epithelial
nests (en) of primitive granulosa cells [87]. The epithelial
nests move through stromal rearrangements into the
lower cortex (lc) [11], where they associate with cortical
vessels (venules) to pick up circulating oocytes.
Under the influence of hormonal and cellular signaling
(HS, CS, Figure 9B) of ovary-committed bone marrow
cells (arrow, Figure 9D) derived from immune system-
related structures supposed to carry an "ovarian me-
mory" (om, [12]), the mesenchymal OSC precursors
(mc, Figure 9B) differentiate into the OSC covering not
the cortex, as above, but the TA layer (ta, Figure 9B),
Blood circulation

























Figure 9 Survey of follicular renewal in adult human ovaries. Follicular renewal in adult human ovaries is a two-step process based on
mesenchymal-epithelial transition of tunica albuginea (ta) bipotent progenitor cells into OSC. A) Epithelial nests: Segments of the OSC directly
associated with the upper ovarian cortex (uc) are overgrown with tunica albuginea, which forms a solid epithelial cord that fragments into small
epithelial nests (en) descending into the lower ovarian cortex (lc) and associating with the blood vasculature. Initiation of this process may
require cellular and other local signaling (CS & LS), possibly neural [87]. B) Germ cells: Under the influence of cellular signaling (CS) of ovary-
committed MDC & T cells (OC-BMC) and hormonal signaling (HS), some OSC covering the tunica albuginea undergo asymmetric division and
give rise to new germ cells (gc). The germ cells subsequently divide symmetrically and enter adjacent cortical blood vessels. During vascular
transport, they are picked up by epithelial nests associated with vessels. D) The ovary-committed bone marrow cells originate from bone marrow
(MDC) and from lymphoid tissues (T cells) carrying "ovarian" memory (om), which diminishes with utilization; when spent, the follicular renewal
ceases, in spite of persisting hormonal signaling (Table 1).
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This is followed by a single symmetric division of germ
cells required for crossing over. Subsequently, the germ
cells enter the upper cortex, associate with blood vessels,
and enter the circulation (arrow, Figure 9B). They as-
semble with epithelial nests of primitive granulosa cells
in the lower cortex (lc, Figure 9C). The circulating germ
cells may contaminate other tissues, including bone mar-
row, and eventually degenerate in the ovarian medullary
vasculature (Figure 7I), to which they appear to have an
affinity for homing. For a schematic description of alter-
native origin of germ cells from epithelial crypts in adult
ovaries (see Figure 7G and [11]).
The rete ovarii is absent in adult ovaries. Ovary-
committed bone marrow cells during adulthood may
originate from bone marrow and lymphoid tissues. It
has been suggested that during fetal developmental im-
mune adaptation an "ovarian" memory is build within
the developing immune system for support of follicular
renewal by ovary-committed bone marrow cells during
adulthood [12]. It appears that the termination of fol-
licular renewal occurs at about 38 years of age, resulting
in a significant decline of oocyte numbers in human
ovaries [89] and an abrupt increase in the rate of pri-
mordial follicle loss [141]. The termination of follicular
renewal is not necessarily due to the lack of germ cells,
which are detected in aging mouse ovaries [142], but ra-
ther due to the lack of formation of new granulosa cellnests (see below). This may be programmed by a signifi-
cantly later emergence of granulosa cells in developing
ovaries (4th month of intrauterine life) compared to the
very early emergence of germ cells (1st month of intra-
uterine life) - see Chapter 4 and below.
7. Developmental immune adaptation and
determination of the aging of the ovary and
other tissues
In normal individuals, the first organ affected by aging is
the thymus [143] and next the ovary in human females
[144,145]. There is a strong correlation between the
period at which an organ is present during early on-
togeny and that organ's functional longevity. For in-
stance the heart, which differentiates very early, can
function more than one hundred years. However, the
ovary, in which the granulosa cells and primordial folli-
cles differentiate later, does not function for more than
half of that time [1]. We have proposed that the later the
differentiation of certain type of tissue occurs during
early ontogeny, the earlier its function expires during
adulthood [66].
During developmental immune adaptation, through
the end of the second trimester of intrauterine life in
humans [28], the differentiating tissues are recognized
by the developing lymphoid (immune) system as self.
However, depending on the time at which a certain tis-
sue arises during developmental immune adaptation, a
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supported by tissue-specific mesenchymal cells. Immune
system-related cells (MDC and T cells) are present in
peripheral tissues, and influence the differentiation of
tissue cells [126], including the formation of germ and
granulosa cells and differentiation of primordial follicles
[87,100].
Monocyte-derived cells play an important role in regu-
lation of the immune system. These cells control the
function of tissue lymphocytes associated with tissue-
specific cellular differentiation [126]. Lymphoid tissues
not only produce cells promoting differentiation of
tissue-specific epithelial and parenchymal cells, but also
receive information from peripheral tissues via afferent
lymph. This information is transmitted by “veiled”
MDC, a subpopulation of tissue MDC. They are HLA-
DR positive, highly immunogenic and present antigens
to T cells in the draining lymph nodes [146-149].
In the fetal ovary presumptive memory cells reside in
the rete ovarii, and immature MDC and T cells migrate
through rete channels toward the ovarian surface. There
they participate in the development of germ cells from
OSC [100]. Similar interactions of immune cells with
OSC were described in the ovaries of adult women [87].
During adulthood, however, no rete is present in ovaries,
so memory cells may reside in the bone marrow and
lymphoid tissues. The immune system shows a signifi-
cant functional decrease between 35 and 40 years of age
[150] and concomitantly ovarian follicular renewal
ceases [11].
7.1. Thymus and reproduction
It has been suggested that thymic peptides play a role in
determining the reproductive lifespan of females
[151,152]. A relationship between age-associated thymic
involution and the diminution of ovarian function is
supported by the alteration of ovarian function seen in
neonatally thymectomized mice [13]. Additionally, in
congenitally athymic (nude) mice, follicular loss is first
evident at two months of age. This is specifically due to
a reduction in the number of primordial follicles. The
initial ovulation is delayed until two and a half months
of age, compared to the first ovulation at one and a half
month old normal mouse females. By four months, an
overall reduction in all fractions of the follicle popula-
tion occurs in nude mice, and ovulation ceases [153].
Interestingly, the absence of the thymus might also be
responsible for the lack of hair in nude mice, due to the
lack of thymus-derived T cells, which may be required
for hair development.
7.2. The working hypothesis
Our working hypothesis on the role of gonadal environ-
ment in the regulation of human oogenesis [132] ispresented in Figure 10. After the indifferent gonad is
populated with primordial germ cells (Figure 10A), the
rete ovarii stimulates differentiation of oocytes from se-
condary germ cells (Figure 10B). During developmental
immune adaptation, the rete is populated by uncommit-
ted MDC and T cells (UMT), from which the MDC dif-
ferentiate into the veiled cells. The veiled cells transmit
information on oocytes from the rete into the develop-
ing lymphoid tissues (curved arrowhead, Figure 10B).
The MDC in the rete ovarii then become ovarian mem-
ory cells able to convert UMT passing through the rete
channels into ovary-committed bone marrow cells.
These ovary-committed bone marrow cells, with appro-
priate hormonal stimulation, induce the development
of germ cells from the OSC (Figure 10C). The number
of veiled cells populating lymphoid tissues increases
further.
When the developmental immune adaptation is termi-
nated, the rete ovarii degenerates and oogenesis ceases,
due to diminution of hormonal signaling (fetal hCG bar-
rier [100]). The ovarian TA develops from OSC (epithelial-
mesenchymal transformation), and the number of ovarian
memory cells (om; the transformed veiled cells) in lymph-
oid tissues is set (Figure 10D).
Around menarche and during the prime reproductive
period, the hormonal signaling and ovary-committed
bone marrow cells resume cyclic oogenesis to replace
aging primordial follicles undergoing atresia (Figure 10E).
The cyclic follicular renewal during adulthood requires a
cyclic supply of ovary-committed bone marrow cells, and
their generation in lymphoid tissues (ovary-committed T
cells in particular) causes depletion of the pool of memory
cells. Hence, the pool of ovarian memory cells in lymphoid
tissues, but not the pool of primordial fetal follicles, is
what is set during mammalian fetal development.
Once the available pool of ovarian memory cells is
consumed, oogenesis and follicular renewal cease, in
spite of the presence of hormonal signaling (Figure 10F).
Remaining adult primordial follicles persist and are uti-
lized until gone. However, the aging oocytes accumulate
genetic alterations and may become unsuitable for ovula-
tion and fertilization. Postmenopausal ovaries are reported
to carry occasional follicles with degenerated oocytes
(reviewed in [144]).
The initial pool of ovarian memory cells in lymphoid
tissues may be reduced due to the retardation of normal
ovarian development during embryonal and fetal im-
mune system adaptation [1]. If the period for which the
primordial follicles differentiate during developmental
immune adaptation is shorter (delayed or terminated
earlier), the period of follicular renewal after menarche
ceases earlier compared to normal ovaries, and POF
with secondary amenorrhea results. The restriction of
primordial follicle development during adaptation may
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Figure 10 Evolution of ovaries during developmental immune adaptation and their behavior during immune competence. A) Primordial
germ cells imprint the OSC for production of secondary germ cells (see Figure 5B vs. 5A). B) Development of rete ovarii and lymphoid tissue (LT).
Uncommitted MDC and T cells (UMT) saturate rete ovarii to be converted into ovary-committed MDC and T cells (OCMT). C) Secondary germ
cells originate by asymmetric division of OSC under the influence of rete-derived OCMT and hormonal signaling. The ovary commitment is also
transferred into draining lymphoid tissues (arched arrows). During the perinatal period immune competence (ic) is initiated, the ovarian memory
(om) is built and the rete ovarii regresses. During childhood the OCMT is available but hormonal signaling is absent until menarche. E) During the
prime reproductive period (from menarche to 38+/-2 years of age) OCMT and cyclic hormonal signaling cause cyclic formation of germ cell and
renewal of primordial follicles. F) After the prime reproductive period the hormonal signalling persists but follicular renewal ceases due to the
lack of OCMT. Reprinted from [132], with permission, © Bentham Science Publishers, Ltd..
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primary amenorrhea (early POF). Primordial follicles
and ovarian memory in the lymphoid system can also be
depleted by cytotoxic chemotherapy. Interestingly, the
incidence of POF after such chemotherapy increases
with age. In women <20 years old the incidence is 13%,
in 20-30 years is 50%, and >30 years is 100% [154]. This
suggests a diminution of ovarian memory in the lym-
phoid system with age and increasing sensitivity to
chemotherapy.
Together, we speculate that a lack of follicular renewal
may be caused by age associated exhaustion of memory
cells in the lymphoid system, which are required to ge-
nerate effector cells that migrate to ovaries and stimulate
the transformation of OSC into primitive granulosa and
germ cells. Premature ovarian failure may be caused
by delayed ovarian development during developmental
immune adaptation [1], by earlier termination of deve-
lopmental immune adaptation, or by cytostatic chemo-
therapy affecting both the existing pool of primordial
follicles and ovary-committed mesenchymal cells
required for follicular renewal. Patients with POF have
been found to have abnormalities in the function of
circulating monocytes, activated lymphocytes, NK cells,and exhibited other immune abnormalities [155-157],
including anti-ovarian autoantibodies [158], suggesting
a relationship of immune system alteration to the
pathogenesis of POF.
7.3. Premature failure of ovaries with primordial follicles
and animal models
Premature ovarian failure is the result of a lack of adult
primordial follicles within the ovaries of women less
than 40 years of age [159]. However, POF is also often
clinically associated with follicular resistance to gonado-
tropins, called "hypergonadotropic amenorrhea.” Here
ovaries contain normal primordial or even antral follicles
not responding to gonadotropins by the production of
estrogens. No woman with primary amenorrhea has
been reported to ovulate or conceive with her own
oocytes, but more than one third of the women with
secondary amenorrhea were pregnant at least once be-
fore developing hypergonadotropic POF. A quarter of
them had evidence of ovulation after the diagnosis was
established, and 8% of those with secondary amenorrhea
later conceived [157].
Animal models (rats and mice) indicate that there are
two types of POF with primordial and antral follicles
Bukovsky and Caudle Reproductive Biology and Endocrinology 2012, 10:97 Page 21 of 45
http://www.rbej.com/content/10/1/97within the ovaries. The first, persistent ovarian immatu-
rity, can be induced by inhibition of ovarian development
(temporary inhibition of androgen receptor expression)
with estrogens during developmental immune adaptation,
while the second, premature ovarian aging, can be
induced by acceleration of ovarian development (prema-
ture expression of an androgen receptor) with androgens
[37,67].
7.4. The tissue control system theory and a "stop-effect"
of monocyte-derived cells
The TCS theory [38,63,65,67,126,160] addresses the role
of vascular pericytes, MDC, and T and B cells in the
regulation of tissue function. It proposes that MDC
stimulate early differentiation of tissue-specific (epithe-
lial, parenchymal, neural, and muscle) cells. Monocyte-
derived cells also regulate expression of epitopes of
tissue specific cells, and in this way control their recogni-
tion by circulating tissue-committed T cells and anti-
bodies. Such T cells and antibodies promote the advanced
differentiation of tissue cells, which ultimately results in
the aging and apoptosis of these cells [126].
By the end of the developmental immune adaptation
in early ontogeny, the MDC encounter the most differ-
entiated tissues in a tissue-specific manner, and prevent
them from differentiating beyond the encoded state by
the so-called "stop effect." The nature of the "stop effect"
may reside in the inability of monocyte-derived cells to
stimulate differentiation of tissue cells beyond the
encoded stage. Retardation or acceleration of certain tis-
sue differentiation during developmental immune adap-
tation causes a rigid and persisting alteration of this
tissue function. The ability of monocytes to preserve tis-
sue cells in a functional state declines with age. This is
accompanied by functional decline of various tissues
within the body, including the ovary, resulting in meno-
pause and an increased incidence of degenerative di-
seases in humans.
In large mammals including primates developmental
immune adaptation is terminated during intrauterine
life, while in small laboratory rodents it continues for
several postnatal days, ending about one week after birth
[28]. Estrogens given to neonatal rats and mice inhibit
ovarian development. During adulthood such rat females
exhibit persisting ovarian immaturity, characterized by
retardation of follicular development [65] despite normal
levels of gonadotropins [161,162]. This shows that
suppression of early ovarian development results in per-
sisting ovarian immaturity, resembling POF and gonado-
tropin resistence of ovarian follicles. Injection of
estrogens in neonatal mice (days 0-3) caused permanent
anovulation, but mice injected later (days 3-6; closer to
the end of developmental immune adaptation) show a re-
sumption of ovulatory cycles after initial anovulation[163]. Hence, persisting ovarian immaturity can result in
delay of normal ovarian function. Since the incidence of
degenerative diseases increases with age, one would ex-
pect a tendency of the "stop-effect" to shift up with age
[1]. This could explain how persistent ovarian immaturity
may change to a functioning ovary.
On the other hand, injection of androgens causes pre-
mature ovarian aging which persists throughout adult-
hood. Androgen-induced anovulation can be prevented
by neonatal injection of a thymic cell suspension from
immunocompetent prepubertal normal female donors,
but not if given from animals prior to completion of de-
velopmental immune adaptation [17]. This suggests that
certain thymic cells (thymocytes, or thymic MDC) of
normal immunocompetent females carry information on
the differentiation of ovarian structures, and this infor-
mation can be transferred to immunologically immature
neonatal rats.
However, when a low dose of androgens is injected
during developmental immune adaptation, the rats ex-
hibit a delayed anovulatory syndrome. Ovaries exhibit
the onset of normal function after puberty (~40 days of
age), but premature aging of the ovary occurs between
60-100 days [164]. This delayed manifestation of ovarian
dysfunction resembles human POF with secondary
amenorrhea, as well as some human degenerative dis-
eases with autoimmune character, which also occur after
a shorter (juvenile diabetes mellitus) or longer (Alzhei-
mer's disease) period of normal tissue function.
An application of the TCS theory on the regulation of
tissue function via the "stop effect" is described in Ref.
[1]. In normal tissues, the functional cells are present
during developmental immune adaptation and the
tissue-specific cells are "parked" in the functional state
during adulthood. Retardation of cell differentiation dur-
ing adaptation results in persisting immaturity (POF
with primary amenorrhea) and an acceleration of prema-
ture aging (POF with secondary amenorrhea, degenera-
tive diseases). If the tissue was absent during adaptation,
like CL, it is handled as a "graft" [160].
Note that the functional stage of cell differentiation
differs between distinct tissue types, being very low in
the vagina (in the absence of hormonal stimulation the
basal/parabasal cells are only present), low in the brain,
skeletal muscle, and pancreatic beta cells (lack of intrae-
pithelial lymphocytes), moderate in the gut (presence of
intraepithelial lymphocytes), and high in the skin (apop-
tosis of surface keratinocytes) [165].
7.5. The immune system memory and aging of the body
The "ovarian memory" built within the lymphoid system
can be viewed as a charged battery, which is drained by
periodical follicular renewal. The higher the charge dur-
ing the developmental immune adaptation, the longer it
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velopmental immune adaptation in the programming of
ovarian function and various types of POF can be extra-
polated to other tissues in the body as well. From this
point of view, the degenerative changes of the immune
system with advancing age could be responsible for the
aging of other tissues and the body in general.
8. Former and current views on ovarian oogenesis
and follicular renewal
8.1. Milestones of the oocyte storage theory
The current belief that all oocytes in adult mammalian
gonads should be from the fetal period was originally
based on the “continuity of germ plasm” theory. It
declared that an essential condition for the development
of another embryo is the retention of a part of the pro-
geny of the primary impregnated germ cell, and that
germ cells have a different character as compared to the
somatic cells, since the somatic cells serve as nurse cells
for the germ cells and cannot be considered as their pro-
genitors [82,166]. This theory assumes that the primary
impregnated cell determines subsequent individuals.
This, however, contrasts with the tenants of evolutionary
theory indicating that surviving species are those who
reproduce themselves, mutate, and are capable of trans-
mitting these mutations into the next generations.
8.2. Oogenesis in adult prosimians
The original report by Gerard on the unique oogenic ac-
tivity from germinal cords in the cortex of the ovary of
adult Galago [84] was followed by studies of ovaries of
adult South Indian prosimians, where the origin of mul-
tiple oocytes from deep invaginations of OSC was
reported [85]. The occurrence of oogonia in adult ova-
ries of other prosimian species was confirmed subse-
quently by many investigators (reviewed in [86]).
Although the fate of such oogonia is a matter of dispute
[167], these observations indicate that new oocytes are
formed in adult prosimians, i.e., primate species appear
evolutionary much more developed than mice in this
regard.
8.3. Rodent ovaries
Edgar Allen was the first to suggest the possibility of fol-
licular renewal in mammals during sexual maturity [78].
Evans and Swezy, in studies of oogenesis in adult guinea
pigs [3], showed that cells move from the OSC into the
ovarian stroma, usually as a solid cord, and one or more
cells become enlarged into oocytes; the remaining cells
form the granulosa cells. Another possibility is that
oocytes are formed along the cord and other cells group
themselves around these, forming primordial follicles
[3]. We observed both mechanisms in normal adult rat
ovaries and showed that a group of cells within thedescending OSC cord express ZP proteins. Some of
these ZP cells are transformed into tadpole-like cells
capable migrating [100]. This enables the development
of adult primordial follicles either directly in adjacent
areas, or via the blood stream in more distant sites. Fol-
licular renewal was also detected in ovaries of neonatally
estrogenized sexually mature rats (ages 45–60 days)
[135].
8.3.1. Functional repair of anovulatory mouse ovaries with
cultured germline stem cells
Former observations indicating that neo-oogenesis
occurs in adult mouse and human ovaries
[11,78,87,90,91,139] were in 2009 confirmed by evidence
that cultured germline stem cells transplanted into the
ovaries of sterilized mice could produce new oocytes
and offsprings [102]. Ji Wu and colleagues studied germ-
line stem cell cultures derived from 5 day old and adult
mouse ovaries, and their ability to produce functional
oocytes when transplanted into the ovaries of infertile
mice [102]. The cultured cells were infected with the
GFP virus and, when transplanted, they were trans-
formed into oocytes and produced offspring expressing
GFP transgene [102]. These observations suggest the
possibility of restoring fertility in women with POF
[168,169].
8.4. Summary on the current views
In conclusion, the prevailing standard for the current
doctrine on the storage of mammalian fetal primordial
follicles with primordial oocytes from the period of ova-
rian development is that the process of oogenesis occurs
only in fetal gonads, and oogonia neither persist nor di-
vide mitotically during sexual maturity with a few pos-
sible exceptions, such as in prosimian primates [81,82].
From our point of view, observations in human ovaries
confirm that oogonia do not persist during sexual ma-
turity, since during the prime reproductive period new
female gametes and granulosa cells originate from bipo-
tential OSC. Observations from ovaries of adult human
and rat females [7,11,87,100,135] and from laboratory
mice [78,90,91,170] support a paradigm that the oocyte
and follicular renewal in adult females during the prime
reproductive period (Figure 1) exists throughout all ani-
mal species (see the prime reproductive period theory -
Chapter 3.1.1.). We are confident that it is just a matter
of time until additional scientists will confirm this.
9. Follicular selection
Ovarian follicles are selected at two occasions. Firstly,
from the cohort of resting adult primordial follicles
some follicles are stimulated to grow. Once selected, the
growing follicles either ovulate or degenerate. Secondly,
during the midfollicular phase in human females one
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late and the other large antral follicles degenerate in
both ovaries.
9.1. Selection of growing (primary) follicles
Within the human ovary, cohorts of adult primordial
follicles occupy distinct areas in the cortex that are char-
acterized by a diminution of Thy-1 protein expression in
stromal cells (dashed line, Figure 11A [11,134]). These
areas exhibit an "ovary-in-ovary" pattern, and stromal
cells show enhanced MHC class I expression (see
Figure 11D and [87]). Most of the adult primordial folli-
cles remain in the resting state (rf, Figure 11A), but































Figure 11 Follicular selection. Selection of secondary (A-D) and preovula
the adult human ovary. Staining for Thy-1, HLA-DR (DR), MHC class I light c
Dashed line in A indicates an "ovary-in-ovary" area exhibiting diminution o
parallel sections to B. Dashed line in E-J, follicular basement membrane. rf,
microvasculature in theca interna (t); vl, vascular layer adjacent to the follic
permission, © Wiley-Liss.transformation into growing (primary) follicles (gf ). Ini-
tiation of follicular growth is triggered by activation
(Thy-1 release) of vascular pericytes (p and black arrow-
heads, Figure 11B) and activated (HLA-DR+) MDC
(semi-parallel section, Figure 11C). The MDC secrete
HLA-DR+ (arrowhead, Figure 11C ), which accumulates
in the nuclear envelope of granulosa cells (black vs.
white arrows; see also the arrowhead in the germ cell,
Figure 8D). Activated MDC also interact with the granu-
losa cells of preantral follicles, at the site of antrum for-
mation [87]. Figure 11D, semi-parallel section to
Figure 11B and C, shows enhanced MHC class I expres-
sion in granulosa cells (arrow) of the growing follicle.




































tory (dominant) follicles (E-G), and large antral follicle atresia (H-J) in
hain (beta 2m) and CD68 of mature MDC, as indicated in panels.
f Thy-1 expression by stromal cells. B) detail from A. C and D are semi-
resting follicles; gf, growing follicle; p, pericytes; e, endothelial cells; v,
ular basement membrane; g, granulosa layer. Reprinted from [134] with
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that vasculature endothelial cells also accompany resting
follicles (white arrowheads, Figure 11D), but such vascu-
lature lacks Thy-1+ (activated) pericytes (white arrow-
heads, Figure 11B).
Why some adult primordial follicles in the given co-
hort initiate growth and other remain resting is not well
understood. Our observations indicate that selective
stimulation of some adult primordial follicles to growth
and development is initiated by activation (Thy-1 re-
lease) of vascular pericytes. Since vessels accompanying
follicles are innervated [112], one may speculate that the
number of adult primordial follicles entering growth in
the given time is controlled by the neural system, which
controls the activity of Thy-1+ pericytes and quantitative
aspects of tissues (reviewed in [63]). Consequently, the
MDC accompanying vasculature are activated too
(arrowhead, Figure 11C), in order to stimulate continu-
ation of follicular differentiation.
In other words, the activity of pericytes of resting adult
primordial follicles is inhibited by vascular autonomic
innervation (AI+). Activity of pericytes in growing (pri-
mary and secondary) follicles is devoid of such inhibition
(AI-). This assumption is supported by the evidence that
tissues lacking autonomic innervation, such as CL and
cancers, show activated vascular pericytes [134].
9.2. Selection of a dominant follicle
In human ovaries, usually only one dominant follicle is
selected for ovulation during the mid follicular phase of
each menstrual cycle. This process of follicular selection
still remains an unresolved puzzle. Premature stimula-
tion with gonadotropins results in multiple mature an-
tral follicles, suggesting that more than one large antral
follicle in the follicular cohort of those developing until
the midfollicular phase is capable of maturing. Hence,
under normal conditions, there seems to be a competi-
tion among growing follicles themselves in an attempt to
reach the mature state and suppress the development of
others. However, in contrast with this traditional view,
our data indicate that the follicles showing more
advanced development of theca interna during selection
are those destined to degenerate [64]. Hence, a critical
role in the process of dominant follicle selection appears
to belong to the theca interna compartment.
Figure 11E shows CK staining of a human dominant
follicle in the mid-follicular phase with multiple CK+
granulosa cell layers (g) adjacent to the follicular base-
ment membrane (dashed line). Under the follicular
membrane is a vascular layer (vl) and theca interna (t)
layers with narrow vessels (v). Staining for Thy-1
(Figure 11F) shows high activity of Thy-1 pericytes
(arrowhead) in the dominant follicle, which is restricted
to the vascular layer. The CD68 MDC (Figure 11G)show no activity within theca interna of the dominant
follicle (arrows) but high CD68 release in the vascular
layer.
Large antral follicles undergoing atresia in the same
ovary show a detachment of granulosa cells from the
basement membrane (g, Figures 11H vs. 11E). This is ac-
companied by marked activation of thecal pericytes (t,
Figure 11I vs. 11F) and dilation of thecal vessels (v). In
addition, the thecal MDC become highly activated
(white arrowhead, Figure 11J vs. arrows, Figure 11G),
but those in the vascular layer in regressing follicle show
virtually no CD68 release (arrow, Figure 11J). Instead,
MDC from the vascular layer invade among detached
granulosa cells (black arrowhead).9.3. Novel aspects of follicular selection
Follicles are selected twice during their development
(preantral from adult primordial follicles and preovula-
tory from antral follicles), but the consequences for the
remaining follicles are different. First, during basal
growth, primary follicles are selected from adult primor-
dial follicles under the control of growth factors of para-
crine origin. Unselected adult primordial follicles remain
in the resting state. The selection of secondary follicles
is associated with activation of pericytes in adjacent
microvasculature, possibly due to permissive signals (i.e.,
lack of inhibition) from autonomic innervation, which is
involved in the regulation of quantitative aspects
(amounts) of specific cells and structures in tissues from
early periods of life [171,172]. Activated pericytes are ac-
companied by activated perivascular MDC. Hence, du-
ring growth initiation, the selected follicles are stimulated
for further development.
After attaining the antral stage, follicles become go-
nadotropin dependent and immature granulosa cells
lacking aromatase can be affected by thecal androgens
[173]. Hence, premature acceleration of theca interna
development may cause follicular atresia via alteration of
immature granulosa cells lacking aromatase by thecal
androgens. This is associated with conversion of follicu-
lar MDC into phagocytes infiltrating the follicular an-
trum. We show that during selection of a preovulatory
follicle, the pericytes in theca interna of nondominant
follicles are highly activated and accompanied by acti-
vated thecal MDC.
In a dominant follicle, activated MDC are present in
the vascular layer adjacent to the follicular basement
membrane, and may stimulate maturation of granulosa
cells (attainment of aromatase expression). In nondomi-
nant follicles, the high activity of pericytes and MDC in
the theca interna may cause enhanced production of
thecal androgens resulting in atresia accompanied by in-
vasion of MDC among immature granulosa cells.
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by a process of temporary retardation of thecal differen-
tiation by a negative influence of autonomic innervation
on the activity of thecal pericytes. Indeed, extracts of
the superior ovarian nerve have been shown to in-
hibit androstenedione production by theca interna
cells [174,175].
Once the dominant follicle matures into the preovula-
tory stage, with the ability of mature granulosa cells to
convert androgens into estrogens, pericytes and MDC in
both thecal and vascular layers show high activity [64].
Taken together, a lack of inhibition of thecal develop-
ment during the midfollicular phase results in fol-
licular atresia and temporary inhibition of thecal
development results in follicular dominance during fol-
licular selection.
9.4. Follicular atresia
Follicular atresia and luteal regression are essential
mechanisms required for the elimination of unnecessary
and aged structures, as well as for normal ovarian func-
tion. Elimination of antral follicles undergoing atresia
and of degenerating corpora lutea during reproductive
years in human females is a fast process, associated with
infiltration of activated macrophages [64,160]. There is
no reason to expect that the similar process accompany-
ing regression of primordial and secondary follicles [11]
will last longer than several days. If at least 60% of all
oocytes in adult human ovaries are in various stages of
degeneration [92], one may conclude that without fol-
licular renewal the ovarian function will cease in human
females within a few months. However, in aging ovaries,
the elimination of degenerating ovarian structures
appears to be altered [176], possibly due to age-induced
alterations of immune system function [176]. Hence,
atresia may not affect primordial follicles in aging ova-
ries [93], and such follicles may persist in spite of an ac-
cumulation of genetic alterations of oocytes.
During the prime reproductive period, degeneration
may affect groups of primordial and secondary follicles.
Immunohistochemically, the follicles undergoing atresia
release ZP proteins into the neighboring stroma. This is
associated with an altered oocyte morphology and
disorganization of the follicular CK+ granulosa layer. In
addition, there is a considerable influx of large macro-
phages into the area from accompanying vessels [11].
Some investigators claim that characteristic morpho-
logical features of primordial follicle atresia are often dif-
ficult to determine (reviewed in [130]), while others are
more confident [93].
In our immunohistochemical study, the assembly of
oocytes with epithelial nests was also associated with
some release of ZP proteins. Formation of new follicles
was characterized by a well-defined oocyte nucleus,intraooplasmic CK+ extensions from the nest cell wall,
and formation of the Balbiani body, i.e., structures and
processes not apparent during follicular regression. Rest-
ing normal primordial follicles and growing secondary/
preantral follicles show regular morphology, with no
leakage of ZP proteins, and only occasional small
tissue macrophages associated with the developing
theca [11].
Enhanced follicular atresia was accompanied by the
appearance of epithelial nests (fragmented epithelial
cords) in adjacent segments of the ovarian cortex. We
have shown that these nests are small CK+ spheroidal
cell clusters of 20–30 micrometers in diameter. There
were also epithelial crypts, likely originating from deep
OSC invaginations. These do not communicate with the
ovarian surface, as evidenced from serial sections. The
movements of epithelial nests and crypts appear to be
caused by a rearrangement of stromal bundles, and their
migration is probably guided by HLA-DR+ (activated)
tissue macrophages. We have also described an alterna-
tive germ cell origin from epithelial crypts in the lower
ovarian cortex (inset, Figure 7G), accompanied by migra-
tion of tadpole like germ cells with ZP+ intermediate
segment (arrowhead, Figure 7H), the presence of epithe-
lial cell nests without oocytes (dashed boxes, Figure 7G),
and the accumulation of primordial follicles in the
neighborhood of epithelial crypts [11] (Figure 7G).
These observations indicate that adult human ovaries
exhibiting atresia of primordial and secondary follicles
initiate formation of new epithelial nests from epithelial
cords with granulosa cell features [122]. This is one of
the prerequisites for the formation of new primordial
follicles. Cortical crypts, consisting of epithelial cells
retaining a relatively embryonic structure of OSC
[122,177], appear to be an alternate source of germ cells.
Germ cells entering the vasculature may reach epithelial
nests at distant destinations, although vascular proximity
is not always a requirement for follicular development
(see Figure 7G).
10. Developmental potential of ovarian stem cells
in vitro
As indicated above, alteration of ovarian function and
the onset of the menopause are associated with the
changes in ovarian immunoregulation. Yet, in OSC cul-
tures, such immunoregulation is absent and the neo-
oogenesis is renewed, including cultures from POF and
postmenopausal ovaries exhibiting a presence of OSC
(Table 2). In addition, our observations also indicate that
OSC show in vivo a strong binding of natural auto-
antibodies (see Figure 4E), which are absent in OSC cul-
tures. This suggests that the OSC have the ability to
differentiate into oocytes if in vivo immunoregulation
is absent.
Table 2 Presence of ovarian OSC and emergence of oogenesis in culture
Case #1 Age2 POF Diagnosis CK+ OSC/ epithelial crypts Oogenesis in primary and secondary cultures Morulae
pre/post
menopause
left ov right ov primary secondary
1 30 POF POF yes yes yes N.A. no
2 36 pre PFD4 no yes yes yes no
3 38 POF POF no no no N.A. no
4 39 pre endometriosis yes yes yes N.A. no
5 40 POF POF yes yes yes N.A. no
6 42 pre fibroids yes no yes yes yes
7 43A pre menorrhagia yes yes yes yes no
8 43B pre fibroids yes no yes yes no
9 45 pre endometriosis yes yes yes yes yes
10 48A pre menorrhagia no yes yes yes yes
11 48A pre fibroids no yes yes yes no
12 493 pre PFD no no no N.A. no
13 503 pre fibroids no no no N.A. no
14 523 post ovarian cyst no no no N.A. no
15 53 post PFD no yes yes yes no
16 55 post uterine bleeding yes no yes yes yes
17 60 post PFD no yes yes yes yes
18 67A post PFD yes yes yes N.A. no
19 67B post PFD yes no yes N.A. no
Evaluation of menopausal status, OSC in ovaries, and presence of oogenesis and morulae in primary and secondary ovarian cultures. Data adapted from [178] and
[94] with permission, © Informa UK Ltd.
1 Age arrangement.
2 Letters are added in patients exhibiting identical age.
3 Perimenopausal women.
4 Pelvic floor disorders (uterine/vaginal prolapse with or without urinary incontinence).
POF, premature ovarian failure; pre, premenopause; post, postmenopause; N.A., not available.
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stem cells
After observations in adult and fetal human ovaries, we
asked ourselves if a similar potential for OSC could be
demonstrated in vitro. Our observations have shown
that oocytes, fibroblasts, and epithelial type cells can de-
velop spontaneously, as well as neuronal cells [7].
10.2. Culture conditions and techniques
The surface of intact ovaries is gently scraped in an
aseptic laminar flow hood with a sterile stainless steel
surgery knife blade No. 21 (Becton Dickinson, Acute-
Care, Franklin Lakes, NJ). This procedure is selected
with the intention to include OSC and some adjacent
TA and ovarian stromal cells.
The cells are collected into sterile petri dishes contain-
ing tissue culture medium supplemented with heat inac-
tivated 20% fetal bovine serum (FBS; Gibco/BRL, Grand
Island, NY) and antibiotics (50 microgram/ml gentamy-
cin, 100 U/ml penicillin, and 100 microgram/ml strepto-
mycin). The tissue culture media utilized is either
Dulbecco's Modified Eagle's Medium containing 25 mMHEPES, 4500 mg/L glucose, and phenol red (DMEM-
HG; with estrogenic stimuli) or Dulbecco's Modified
Eagle Medium/Ham's F12, phenol red free (DMEM/F12;
without estrogenic stimuli). No other treatment is
imposed during the culture.
The cells are spun down (1000 × g, 5 min, 24 degrees
C), diluted in 0.75 – 1.5 ml of supplemented media,
seeded in either 6 or 3 wells of a 24-well plate (250-350
microliters per well) (Fisher Scientific, Pittsburgh, PA),
and cultured in an humidified atmosphere with 5% CO2
at 37 degrees C. The number of wells is chosen by the
size of ovaries. Cells collected from larger ovaries are
seeded into six wells, and from small ovaries are seeded
into 3 wells. All ovaries involved in the experiment were
anovulatory, and no CL detected. The culture medium
was changed once after 24 hours. This left only adherent
(viable) cells in culture, and eliminated non-adherent
cells and the majority of contaminating erythrocytes.
The cell cultures were monitored daily by phase contrast
microscopy and live cells evaluated by immunohisto-
chemistry after 5–6 days from the initial seeding. Viabil-
ity of cells is apparent from their active movement,
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number of adherent cells in a single well of 24-well plate
ranged between ~100 to 1000 during the late culture
period (day 5 or 6).
10.3. Estrogens are essential for the neo-oogenesis
in vitro
The OSC cultures maintained in DMEM-HG with estro-
genic stimuli (phenol red) showed large cells exhibiting
the phenotype of oocytes on day 5. These cells reached
100–180 micrometers in diameter and showed a cen-
trally located germinal vesicle break-down with nucleus
and nucleolus (see Figure 12A).
In contrast, utilization of DMEM/F12 without estro-
genic stimuli in another culture from the same patients
produced no large cells exhibiting an oocyte phenotype
on day 5. However, 12 day cultures of ovarian cells
showed the presence of oocytes. It is thought that na-
tural estrogenic stimulation is provided by ovarian stro-
mal cells that accompany OSC in culture.
It was found that stromal tissue from human ovaries
produces progesterone, androgens, and estrogens
in vitro [180]. In addition, ovarian stromal cells produce
in vitro high levels androgens similar to that of the the-
cal cells [181]. These androgens can be converted into
estrogens by fibroblasts [182] present in OSC cultures
[7]. The OSC are also capable of secreting hCG [183]
and steroid hormones, including estrogens [133]. Hence
















Figure 12 Oocyte and parthenote development in vitro. A) The oocyte
arrow) and neuronal (white arrow) cells. Black arrowheads indicate organel
indicates neuronal extension. Note ZP staining of fibro-epithelial cells (f) bu
Sperm associate (arrowheads) with fibroepithelial cells (B) but not with the
blastocoele (bc), and inner cell mass (icm). (A) shows staining for ZP protei
staining of the fixed culture. Adapted from [179], © Cambridge University POSC into oocytes in vivo (Table 1) also can be achieved
in vitro. The OSC cultures without estrogenic stimuli
showed the presence of granulosa type cells on day 5 [7].
It is useful to mix the 5 day OSC cultures with and with-
out estrogenic stimuli from the same patient in order to
accelerate the oocyte maturation. The granulosa cells
from culture without estrogenic stimulation may provide
the Balbiani body [11] and contribute to the expression
of ZP proteins by developing oocytes [184]. Since ZP
proteins are sperm ligands [185], their expression by
in vitro developing oocytes may preclude the need for
utilization of intracytoplasmic sperm injection (ICSI) for
their fertilization (see below). In vivo, new granulosa
cells develop in functional ovaries from OSC during the
mid follicular phase, when the estrogenic stimuli and LH
levels are low, and new oocytes are formed during the
periovulatory period, when the estrogenic stimuli and
LH levels are high [11,87].
It requires twice as long for cultures initially lacking
estrogen to reach a level of estrogens produced by ovar-
ian stromal cells compared to media with sufficient ex-
ogenous estrogen (phenol red) level from the beginning
of culture.
10.4. Development of oocytes and parthenogenetic
embryos in vitro
10.4.1. Primary ovarian stem cell cultures
The advanced development of oocytes (o, Figure 13A)
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Figure 13 In vitro developing oocytes supplied with organelles from fibroblasts resulting in fibro-oocyte hybrids, or by satellite cells
produced by the oocytes and exploited for the progression of the oocyte growth. Images from time lapse photography (time in hours:
minutes). A) In vitro developing oocytes (o) deficient in organelles (white arrow) can be joined (arrowhead) by a fibroblast (fb and white
arrowhead). B) The optically dense organelles are supplied to the oocyte. C) Alternatively, the oocyte is supplied by adjacent satellite cell (s) with
an extended tube (black arrowhead; see detail in inset). D) When completed, the tube disappears (inset) and the satellite is regressing (rs). E) In
contrast, the fibroblast moves above the oocyte and releases organelles out (white arrowhead) of the regressing oocyte (ro). F) Subsequently, a
fibro-oocyte (fbo) hybrid is formed exhibiting oocyte remnants (ro). Bar in A for A-F. Panels A-D adapted with permission from [9], © Wiley-Liss,
Inc, and complemented with E and F.
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arrow) substituting a granulosa cell-derived Balbiani
body to provide additional organelles (black arrowheads)
needed by the developing egg. To increase the volume of
the oocyte, the human granulosa cell microvilli penetrate
in vivo deep into the ooplasm of developing oocytes and
supply a variety of organelles such as Golgi vesicles,
endoplasmic reticulum membranes, and nascent forms
of smooth endoplasmic reticulum [136].
In vitro, neural type cells are also involved (white
arrow, Figure 12A) with an extension (white arrowhead)
over the developing oocyte. Note a strong expression of
ZP proteins in fibro-epithelial cells on the cell surface
but lack of ZP expression at the oocyte surface (red
arrow). The presence of sperm causes their association
(arrowheads, Figure 12B) with fibro-epitheial cells (f ),
but not with the oocytes (Figure 12C), due to the lack of
surface ZP expression (red arrow, Figure 12A).
Eventually, some oocytes differentiate into parthenotes
with a trophectoderm (te, Figure 12D and E), blastocoele(bc) and inner cell mass (icm) [179], similarly to some
oocytes in in vitro fertilization (IVF) cultures [186]. This
indicates that the OSC-derived oocytes developed
in vitro are functionally similar to the mature follicular
oocytes. The lack of ZP expression at the surface of
in vitro developed oocytes, will, however, mandate the
utilization of ICSI for their fertilization.
Images from time lapse photography show that early
developing oocytes (o, Figure 13A) are low in optically
dense cytoplasmic organelles (white open arrow). They
can be joined (arrowhead) by fibroblast-type cells (fb)
which provide additional organelles. Such fibroblast-
type cells initially show optically dense organelles
(black solid arrow) close to the nucleus, but not in the
arm extended toward the oocyte (white solid arrow).
Within 10 min (Figure 13B), however, optically dense
organelles are apparent in the extended arm (solid
black arrow) within adjacent oocyte cytoplasm (black
arrowhead) and in distant oocyte regions (open black
arrow).
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cient in the cytoplasmic organelles (white arrow) are
supplied by satellite cells (s), i.e., nurse cells, which are
produced by the oocytes themselves (see below). The
satellite cell shows an extended tube (black arrowhead;
see also detail in the inset) providing the cytoplasm with
organelles for the oocyte. Figure 13D (1 hour, 39 min
from Figure 13C) shows that when such a process is
completed, the oocyte exhibits an enhanced content of
the optically dense organelles (black arrow, Figure 13D)
and the tube draining the satellite cell disappears (white
arrowhead – see detail in the inset). The satellite cell
size is reduced (dashed line) and the content is altered
(compare with Figure 13C).
The fate of oocytes supplied by fibroblasts is, however,
different. Figure 13E (1 h, 47 min from Figure 13A)
shows that the fibroblast moves above the oocyte and
releases the organelles out (white arrowhead) of the
regressing oocyte (ro). Figure 13F (4h, 25 min) shows fu-
sion of the fibroblast (rich in organelles - black arrow-
head) with a structure showing oocyte remnants (or)
lacking organelles (white arrow), a so-called fibro-oocyte
(fbo) hybrid.
Figure 14A shows an early stage after oocyte (o) di-
vision producing the satellite (s) cell. Note a similar con-
tent of cytoplasmic organelles; asterisks indicate former
(regressing) satellites. Figure 14B indicates that oocyte
growth is accompanied by a regressing satellite (rs) exhi-
biting nuclear alteration and vacuolization in the peri-









Figure 14 Oocyte satellites in vitro. A) Early stage after oocyte (o) divisio
satellites. B) Oocyte growth and regressing satellite (rs) with vacuolization i
its separation (arrowhead) from the satellite remnants (sr). D) Large isolated
cytoplasmic membrane. Panels A-D adapted with permission from [9], © Wcytoplasmic organelles compared to the satelite in
Figure 14A. Figure 14C shows progressive oocyte growth
and its separation (arrowhead) from the satellite cell
remnants (sr). A large isolated oocyte (Figure 14D) exhi-
bits germinal vesicle (gv) and a thick ZP cytoplasmic
membrane (zp).
10.4.2. Secondary ovarian stem cell cultures
Primary OSC cultures can be trypsinized and stored fro-
zen for additional utilization. Figures 15A-C show
images from time lapse cinematography of oocyte devel-
opment in secondary OSC culture, beginning four hours
after seeding (F36, 36 year old woman - for the OSC
presence in the ovarian biopsy see Chapter 10.7). An
early developing cell (Figure 15A, time 1 min, 15 se-
conds of cinematography) shows a cytoplasmic tail
(arrowhead). At 18 min, seven seconds multiple cyto-
plasmic eruptions (arrowheads) are evident (Figure 15B).
At 31 min, 14 seconds the 40 micrometers oocyte-like
cell developed (Figure 15C, yellow arrowheads indicate a
cell surface, red arrowhead a polar body). This video is
available as Additional file 1, supplemental video S1.
Panels 15D-F show a secondary OSC culture from a
55 year old postmenopausal women (for OSC in the
ovarian biopsy see Chapter 10.7) stained for ZP afer
three days of seeding (d3sc ZP). Oocyte precursors can
produce, by several divisions, a "chain" of satellite cells.
Such a chain is presented in Figure 15D. Note that cells
in the chain are interconnected by intercellular bridges
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Figure 15 Differentiation of early oocytes and behavior of oocytes in secondary OSC cultures. A-C) Time lapse cinematography of oocyte
development in secondary OSC culture. A) Early developing cell with a cytoplasmic tail (arrowhead). B) Multiple cytoplasmic eruptions
(arrowheads). C) Development of the 50 micrometers oocyte-like cell (yellow arrowheads indicate cell surface, red arrowhead a polar body). Time
in minutes':seconds". Movie segments are available in the Additional file 1, supplemental video S1. D-F) Day 3 secondary OSC culture stained for
ZP (d3sc ZP) - 55 year old postmenopausal women three days afer seeding. D) Oocyte (o) with a "chain" of satellite cell (s), regressing satellites
(rs), and satelite remnants (sr) interconnected by intercellular bridges (open white arrowheads) and surface ZP expression (open black
arrowheads). The "leading" oocyte shows formation of the cell surface in the bridge (solid yellow arrowhead). Asterisk indicates cell nucleus and
red arrowhead developing polar body. E) Two "leading" oocyte type cells with surface ZP expression, each of which shows expulsion of two
polar bodies (red arrowheads) and retention of two pronuclei (asterisks). Yellow arrowheads indicate a line of separation from remnants of the
"satellite" cells lacking surface ZP. F) Large oocyte (140 micrometers) with surface ZP expression (arrowhead), nucleus (asterisk), and germinal
vesicle (gv).
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rent on their surface (open black arrowheads).
The last cell in the chain represents satellite remnants
(sr). Regressing satellites (rs) follow, and a large satellite
(s) is close to the developing oocyte (o) leading the
chain. The developing oocyte shows formation of the
cell surface in the bridge (solid yellow arrowhead). An
asterisk indicates the leading oocyte nucleus and the red
arrowhead a developing polar body. Figure 15E shows
two "leading" oocyte type cells with surface ZP expres-
sion, each of which shows expulsion of two polar bodies
(red arrowheads), retention of two pronuclei (asterisks),
and surface ZP expression (open black arrowheads). Yel-
low arrowheads indicate a line of separation from a
regressing satellite (rs) and satellite remnants (sr) lacking
surface ZP. A large oocyte ( micrometers) with a nucleus
(asterisk), germinal vesicle (gv), and surface ZP expres-
sion (open black arrowhead) is shown in Figure 15F.
These observations resemble the formation and fate of
Drosophila melanogaster ovarian cysts (egg chambers).
In Drosophila, ovarian cysts are produced through a
series of synchronous mitotic divisions during which
cytokinesis is not completed. After completion of four
mitotic divisions, all 16 cells enter the premeiotic S
phase. However, only the true oocyte at the center of thesyncytium remains in meiosis and continues to develop.
The remaining 15 cells lose their meiotic features and
develop as polyploid nurse cells. In contrast to nurse
cells, the oocyte remains in prophase of meiosis I until it
proceeds to the first meiotic metaphase late in oogenesis.
The oocyte fate is dependent on the unique presence of
the missing oocyte (mio) gene, which is required for the
maintenance of the meiotic cycle and oocyte identity.
Mio associates with the conserved nucleoporin seh1,
which influences the oocyte development. In drosophila
females lacking seh1 about 20% of egg chambers develop
with 16 polyploid nurse cells and no oocyte (for data
and review see Ref. [180]). Oocyte syncytia (ovarian
cysts) also develop in mouse and human fetal ovaries
[112,187,188].
10.4.3. Ovarian stem cell cultures vs. in vivo oocyte and
follicular development in mammals
The behavior of developing oocytes in human OSC cul-
tures resembles their behavior in ovarian cysts, from
adult Drosophila to mouse and human fetuses. In other
words, the oocyte development from human OSC
in vitro may utilize the mio gene and nucleoporin seh1
mechanisms to produce own nurse (satellite) cells,
thereby preventing them from developing into additional
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to differentiate into parthenotic embryos (Figure 12D
and E, and below), like some cultured follicular oocytes,
the in vitro developed oocytes are functionally
competent.
In adult inverterbrates and lower vertebrates (fish, am-
phibia), all periodically developed oocytes are ovulated.
In higher vertebrates, however, each oocyte lies in the
ovarian follicle, where its further development is
dependent on the activity of granulosa cells providing
additional organelles required by growing oocytes
(Balbiani body). The activity of granulosa cells is regu-
lated by the follicular TCS niche (see Figure 11A-D). In
addition, the selection of dominant follicle(s) (Figure 11E-J)
ensures the number of ovulations in a species specific
manner, which is optimal for the maintenance of the cer-
tain number of fetuses during pregnancy. Therefore, once
granulosa cells are available during ontogeny, the develop-
ment of oocytes into ovarian cysts with nurse cells is
switched into follicular development (Figures 2, 3 and 4).
In vitro, the follicles with granulosa cells and the TCS
niche are absent, so oocytes developing from OSC utilize
the developmentally primitive mechanism of ovarian cysts
formed by the oocyte and its nurse cells.
10.4.4. A comparison of the primary vs. secondary ovarian
stem cell cultures
Our observations indicate that the behavior of primary
and secondary OSC cultures are different. The primary
OSC cultures contain ovarian stromal cells, which con-
tribute to oocyte growth and development. Such oocytes
show the ability to develop into parthenotes, similarly to
some follicular oocytes during standard IVF techniques.
This suggests that in vitro developed oocytes are in
principle similar to the cultured follicular oocytes. The
lack of expression of ZP proteins at the developed oo-
cyte surface will, however, require ICSI for their
fertilization, unless they are stimulated to express ZP by
granulosa cells from primary OSC cultures without es-
trogenic stimulation. Secondary OSC cultures utilize a
developmentally ancient mechanism known from the
Drosophila ovaries. They produce their own satellites for
the oocyte maturation and mature oocytes express ZP
proteins. This may be useful for standard oocyte
fertilization. Yet, the targeted ICSI may still be found
useful for the fertilization of the selected oocytes.
10.5. Development of embryonic stem cells from in vitro
developed parthenotes
DAZL protein, expressed in human oocytes, preimplan-
tation embryos, and ESC [106], is strongly expressed in
early (four cell stage) parthenotes (Figure 16A-C).
Resulting morulae (Figure 16D and E, no immunohisto-
chemistry) may develop into blastocysts producing`DAZL+ ESC from the embryonic inner cell mass
into the culture (arched arrow and esc, Figure 16F).
The inner cell mass and the released ESC are mitoti-
cally active compared to the other cells lacking
DAZL expression and by pronounced DAPI staining
(arrowhead in left vs. no mitoses in the right inset,
Figure 16G) [179].
These observations indicate that OSC cultures could
be sources of eggs for the treatment of female ovarian
infertility, and can also produce ESC for autologous re-
generative medicine.
10.6. Development of oocytes from postmenopausal and
POF ovaries
Ovarian cultures derived from atrophic postmenopausal
ovaries are capable of producing new oocytes, some of
which differentiate into parthenogenetic morulae, sug-
gesting their functional potential. Apparently, the OSC
may differentiate and proliferate during advanced post-
menopause [134,178] and in young women with POF
[94,189-191].
10.7. Cultures from ovaries lacking ovarian stem cells fail
to produce oocytes
The presence of OSC in ovaries has been found essential
for the development of oocytes in ovarian cultures.
Figure 17A shows CK+ OSC (arrowhead) in the ovary of
a 36-year old woman (F36). However, perimenopausal
ovaries (around 50 years of age, ages 49–52 in our obser-
vations - see below) often lacked OSC (Figure 17B), as
well as some ovaries (one of three cases) of women with
POF [94]. On the other hand, women in advanced
menopause exhibited OSC regularly [134]. Figure 17C
shows the ovary of a 55-year old women exhibiting CK+
OSC on the ovarian surface (white arrowhead). Ovarian
stem cells are also present in the cortical crypt in the
deeper cortex (yellow arrowhead). Ovarian culture of the
50-year old female (Figure 17D) showed only narrow
fibroblasts. Note a lack of OSC in Figure 17B. A cluster
of epithelial type cells was observed in culture from the
55-year old postmenopausal female (Figure 17E). Note
OSC in Figure 17C. Detail from another cluster of epi-
thelial cells showed a 30 micrometer round oocyte-type
cell (arrowhead, Figure 17F) with a prominent nucleus.
A large (120 micrometers) round oocyte type cell with a
germinal vesicle (gv) and thickened plasma membrane
(arrowhead) was also detected (Figure 17G).
These observations show that ovaries lacking OSC are
unable to produce oocytes in ovarian cultures. The pres-
ence of OSC is essential for in vitro oocyte development.
The OSC usually persist in postmenopausal ovaries,
serving as a source for development of epithelial cell
clusters in ovarian cultures. Some of these OSC-derived
epithelial cells appear to be precursors of gradually
Figure 16 Parthenotes in OSC cultures. A-C) Four cell embryo. D and E) morula. F and G) Blastocyst consisting of blastocoele (bc),
trophectoderm (te) and inner cell mass (icm) releasing (arched arrow) DAZL+ embryonic stem cells (esc). Scale in C for A-C. A, C and F - Dazl
staining, B, E and G - DAPI. Adapted with permission from [179], © Cambridge University Press.
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thenogenetic embryos in ovarian cultures, which can
also be observed during oocyte handling for standard
IVF purposes [186], indicates the functional similarity of
in vitro developed eggs with cultured follicular oocytes.Figure 17 Influence of the presence vs. absence of OSC in the ovary
ovaries (A-C); note a lack of adult primordial follicles in all samples. A) Stain
in the ovary of 36 years old woman (F36). B) Ovary of 50 years old women
year old ovary. The OSC is also present in the cortical crypt (yellow arrowh
ovarian cultures (d6pc). D) Ovarian culture of a 50 year old female shows o
epithelial type cells in culture from a 55 year old female (note OSC in pane
micrometers) round oocyte type cell (arrowhead) with a prominent nucleu
vesicle (gv) and thickened plasma membrane (arrowhead).Development of oocytes from OSC derived from ovaries
with no naturally present follicles and oocytes (POF and
postmenopausal women) [94,189] confirms the ability of
OSC to produce new eggs in the absence of OSC niche
present during neo-oogenesis in vivo.on ovarian cultures. Occurrence of OSC in pre- and postmenopausal
ing for CK with hematoxylin counterstain shows CK+ OSC (arrowhead)
without OSC. C) Activity of the TA (white arrowhead) with OSC in 55
ead) in the deeper cortex. (D-G) Phase contrast from live day 6 primary
nly narrow fibroblasts (note lack of OSC in panel B). E) Cluster of
l C). F) Detail from another cluster of epithelial cells shows small (30
s. G) Large (120 micrometers) round oocyte type cell with germinal
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ing to the patient's age are summarized in Table 2. There
were three POF cases, out of which two cases (#1 and
#3) exhibited OSC and exhibited oogenesis in vitro. No
oocytes in culture were observed in case #2 lacking OSC
in their ovaries. Three perimenopausal women (ages 49–
52) lacked OSC in the ovaries and produced no oocytes
in vitro. It is possible that during the perimenopausal
period altered immune physiology causes an alteration
of the OSC differentiation from TA precursors.
11. Oocyte formation by mitotically active germ
cells purified from ovaries of reproductive-age
women
11.1. Repowering the ovary
In a recent article in Science–Business eXchange (SciBX)
of the Nature Publishing Group [104], the Senior Editor
Tracey Baas indicated:
“Up until the 1990s, the central dogma of reproductive
biology was that female mammals have a restricted ca-
pacity for generating oocytes before birth, and once born
the ovaries cannot renew egg cells that die because of
aging or disease. Consequently, infertility resulting from
oocyte loss had been considered irreversible.
However, multiple papers now cast doubt on that be-
lief through the identification of a population of stem
cells that give rise to functional oocytes.
First, Antonin Bukovsky and colleagues at The Univer-
sity of Tennessee Knoxville published in the American
Journal of Reproductive Immunology in 1995 that a sub-
population of human germline stem cells, now known as
oogonial stem cells (OSCs), could be collected from the
ovaries of women undergoing surgery and used to gener-
ate what were perceived as oocytes in cell culture, based
on detection of oocyte markers [7,11].
Almost a decade later, Jonathan Tilly and colleagues at
Massachusetts General Hospital (MGH) and Harvard
Medical School (HMS) produced multiple datasets that
ran counter to the belief that germline stem cells dis-
appear from ovaries at birth [91].
In 2009, Ji Wu and colleagues at Shanghai Jiao Tong
University used a unique biomarker of murine OSCs—
dubbed DEAD box polypeptide 4 (Ddx4)—to isolate
OSCs from adult mouse ovaries. The team used the
marker to purify OSCs, which were transplanted into
ovaries of infertile mice to generate functional oocytes
capable of producing offspring .
Those data were published in Nature Cell Biology. The
open question was whether OSCs purified from humans
had a similar ability to generate functional ovarian
follicles.
To answer that question, researchers at MGH and
HMS started by modifying Wu’s Ddx4-based purification
protocol to improve its selectivity for OSCs. The team,which was once again led by Tilly, used fluorescence-
activated cell sorting (FACS), which is less likely to be
contaminated by oocytes than Wu’s technique of mag-
netic bead sorting.
His group isolated DDX4-positive cells from murine
ovarian tissue as well as from human ovarian tissue
derived from whole ovaries of reproductive-age women
undergoing elective surgery. In vitro, both human and
murine DDX4-positive cells expressed primitive germ-
line markers but not oocyte markers, suggesting the pro-
cedure had indeed purified OSCs. To determine whether
the OSCs could differentiate into viable oocytes, the
team cultured the cells on mouse embryo fibroblasts
used as feeder cells, which supplied a cellular matrix
upon which the stem cells grew. The human and mouse
OSCs spontaneously differentiated into oocytes, as
assessed by morphology, gene expression patterns and
progression through meiosis.
The next step was to look at whether the OSCs could
generate oocytes in vivo. To do so, the team engineered
the mouse and human OSCs to express GFP, which
made it possible to visualize and track the cells. When
GFP-expressing mouse OSCs were injected into the
ovaries of mice, primary ovarian follicles developed that
contained GFP-positive oocytes. Moreover, those oocytes
led to the development of GFP expressing mouse
embryos following fertilization.
Finally, GFP-expressing human OSCs were injected
into human ovarian tissue and transplanted into immu-
nodeficient mice. The result was primary ovarian folli-
cles that contained GFP-expressing oocytes.
That suggested OSCs might indeed give rise to func-
tional oocytes if transplanted into humans.
Results were published in Nature Medicine [103]. The
team also included researchers from Saitama Medical
University. Tilly and colleagues are now optimizing the
conditions for production of human oocytes in vitro
and have started studies to assess whether OSCs in
nonhuman primates can generate functional oocytes for
IVF.
Bukovsky, professor of reproductive biology associated
with the Institute of Biotechnology of the Academy of
Sciences of the Czech Republic, said he is most inter-
ested in seeing the work translated from ovarian tissue
obtained from reproductive-aged women to women with
ovarian failure who are unable to produce follicle cells
or oocytes. “Tilly’s work supports the existing idea that
purified germ cells transplanted into mouse ovaries will
utilize existing immature follicle cells to produce new
follicles and that the survival and function of oocytes
in vivo requires interaction with these immature follicle
cells,” he said. “It will be very important that the team
reproduce the experiments using ovarian tissue biopsies
obtained from reproductive-aged women and from
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much like to see the mechanistic details”.
Questions aside, Oktay said the new study is “a game
changer because it increases the options available for
obtaining viable eggs. When it comes to fertility restor-
ation, it is all about options”.
Wu, professor of molecular reproduction and stem
cell biology at the Bio-X Center of Shanghai Jiao Tong
University, thinks there are still unaddressed technical
challenges. “It is very satisfying to see our protocol
optimized and fine-tuned to obtain and differentiate
human female germline stem cells into oocytes, but the
team’s culturing conditions will have to be optimized
to avoid use of animal components, and mouse feeder
cells will need to be replaced with either human feeder
cells or a nonfeeder culturing system,” Wu told SciBX
[104]”.
For complete SciBX article see Additional file 2,
Supplemental material.
The article published in Nature Medicine [103] indi-
cates that primitive germ cells purified from the cortex
of functional adult human ovaries form new ovarian
follicles when injected into human ovarian cortical bi-
opsies and xeno-transplanted into immunodeficient
NOD-SCID mice. The article is important, since it is
the first confirmation of former observations on neo-
oogenesis and follicular renewal in adult human ovaries
published in 1995 [87] and expanded thereafter
[7,11,68,94,134,135,139,192]. In addition, neo-oogenesis
from secondary germ cells is already present in human
fetal ovaries, during the second trimester of pregnancy
[9,100].
It has to be noted, that the earlier rarely used term
“oogonial stem cells” [193-195], now considered as a
new term [103], is doubtful, since such cells are in reality
well known germ cells capable to proliferate, originating
in fetal and adult human ovaries by asymmetric division
of OSC progenitor cells (see Chapters 4-6), and not per-
sisting in adult ovaries from the fetal period.
In a recent commentary [10], Telfer and Albertini
indicated:
“Work of White et al. [103] represents an advance
that has the potential to change the nature of future
infertility treatments, although many practical and
conceptual obstacles remain before the clinical utility
of their methods can be realized. Much effort will be
required to improve the efficiency of isolation and
transformation of OSCs into oocytes, as the number
of OSCs that went on to form follicle-enclosed
oocytes in the study by White et al. was small.”
Even in the case of the mouse studies, very few GFP-
positive oocytes were shown to fertilize and undergoeven minimal embryogenesis, with many of these
oocytes clearly arresting at the preblastocyst stage. Fur-
ther, a more detailed characterization of genetic integrity
(euploidy and the appropriate retention of epigenetic
marks) and other hallmarks of oocyte quality (such as
meiotic and developmental competence) are required
before any clinical application of these techniques can
be considered.
Given the response to earlier work from this labora-
tory, questions will undoubtedly linger as to whether
these cells are only activated in vitro or whether they in-
deed contribute to de novo neo-oogenesis in vivo. Fur-
ther research will be required before these issues can be
fully resolved. Nonetheless, the findings of this study will
change the tone of future discourse on the subject to-
ward measured enthusiasm and, most importantly, will
prompt speculation and tempered progress into what
remains a major obstacle in the treatment of various
forms of human infertility [10]”.
In an additional commentary [196] Oatley and Hunt
indicated:
“For OSCs, doubt will persist until clear evidence is
provided that they give rise to genetically normal,
developmentally competent eggs. In the meantime,
skeptics are plagued by several nagging questions:
What do these cells do in the ovary? Where do they
come from? And, most importantly, if they can and
do give rise to viable eggs in the adult ovary, why is
female reproduction of such limited duration? [195].”
11.2. The importance of the presence of uncommitted
granulosa cell nests for the preservation and
development of transplanted primitive germ cells
It has been shown that the survival and function of
oocytes in vivo require their interaction with granulosa
cells, and the number or activity of granulosa cells may
restrict function of female germ cells [11,196]. In human
ovaries, follicular renewal is initiated by the formation of
granulosa cell nests from the bipotent TA precursors,
and they are transported into the deep ovarian cortex
[11,87] (Figure 6). Germ cells subsequently develop by
asymmetric division of the OSC (see Figure 8A and B),
symmetrically divide in the TA (Figure 8C), migrate
from the TA into the upper ovarian cortex (Figure 8C
and D), where they associate with and enter cortical
blood venules (Figure 8E and F). Some of the circulating
germ cells are captured by uncommitted granulosa cell
nests associated with ovarian vasculature in the deep
ovarian cortex (Figure 7B and 9C). Once committed, the
granulosa cell nests form a Balbiani body in the ooplasm
(asterisk, Figure 7C) and a new "primordial" follicle
(Figure 7D). Germ cells originating from the OSC crypts
in the deep ovarian cortex migrate toward neighboring
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(Figure 7G and H), or enter ovarian vasculature to circu-
late and search for uncommitted nests within vessels.11.3. A lack of uncommitted granulosa cell nests causes a
degeneration of the germ cells
If or when such nests are not available, the remaining
germ cells within several days increase to the 50 micro-
meters oocyte size, show profound cytoplasmic ZP ex-
pression, and degenerate, either within the ovarian
medullary vessels (Figure 7I, and Figure 18A-D and F)
or elsewhere else (Figure 18E). Figure 18G shows the ZP
expression limited to the oocyte surface in a normal sec-
ondary follicle.
The availability of transplanted germ cells in adult
human ovaries lacking uncommitted granulosa cell nests
may not be sufficient for follicular renewal [192]. Unlike
mice, adult women with ovarian failure do not exhibitZP4 MA-1671
A B





Figure 18 Intravascular degenerating human oocytes. Degenerating o
endocervical stroma (E) expressing zona pellucida proteins identified by M
to ZP1 was kindly provided by Dr. Satish K Gupta. Arrowheads indicate uns
ZP expression at the oocyte surface in a normal secondary follicle. F28-F38
permission, © Elsevier.uncommitted granulosa cell nests [94,199] compared to
women with follicular renewal [11,87].
11.4. Alternative approaches for the treatment of ovarian
infertility
An alternative approach for human females with ovarian
infertility, most of which exhibit OSC regardless of their
age, is the in vitro development of new oocytes from
OSC in the presence of ovarian stromal cells [7]. Ova-
rian stromal cells are capable of producing androgens
and estrogens [180,181], which accelerate oocyte forma-
tion from OSC in vitro [7]. In addition, the ovarian stro-
mal cells neighboring the oocyte are transformed into
satellite cells and substitute granulosa cell-derived Bal-
biani bodies to provide additional organelles required by
the growing oocyte. Such oocytes are capable differen-
tiating and maturing [9]. They must be fertilized [94] by
intracytoplasmic sperm injection, as they have no signifi-










ocytes in venules of ovarian medulla (A-D and F) and uterine
Ab clones against ZP3, ZP4 and ZP 2 [198] as indicated in panels. MAb
tained oocyte nuclei, arrow in F shows an arteriole, arrow in G shows
indicate patients’ ages. Panels A and C adapted from [139] with
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malcy can be utilized for assisted reproductive
technology.11.5. Restoration of the OSC niche after chemotherapy
Ovarian infertility is caused by alteration of the OSC
niche normally consisting of vascular pericytes, immune
system-related cells sensitive to chemotherapy (mono-
cyte-derived cells and particularly CD8+ T cells), and
autonomic innervation [1,9]. In cancer patients, it
should be possible to collect bone marrow or circulating
white blood cells prior to chemotherapy, and return
them thereafter back to the patient to restore the OSC
niche [200].12. Neo-oogenesis in vitro vs. conventional IVF
Previous in vitro observations of other investigators, in-
cluding IVF practices, dealt with established follicular
oocytes collected from mature ovarian follicles. Follicu-
lar oocytes show a uniform pattern, since they have
already accumulated organelles supplied by granulosa
cells (Balbiani body) and a thick ZP membrane. Cultures
of follicular oocytes do not contain satellite cells, which
appear to be involved in the stimulation of oocyte deve-
lopment in OSC cultures [7,179]. In contrast, oocytes
evolving de novo in ovarian cultures show a different
morphology during sequential stages of development
which cannot be observed in follicular oocyte cultures.
Conventional IVF with autologous follicular oocytes is
usually not used in women over 40 years of age, due to
failure rate of implantation as well as the increasing inci-
dence of fetal abnormalities. The live birth rates in IVF
under age 31 are 66-74%, and decline thereafter, being
18-27% for ages 41 and 42, and 6-11% for age 43 or
higher, reportedly due to the diminished ovarian reserve,
since the rate is 60-80% for all recipient ages using
donor eggs [201]. In contrast fresh oocytes develop de
novo from OSC in culture regardless of the female age.
Therefore, in vitro newly developed oocytes could be uti-
lized for IVF in women exceeding 40 years of age with
improved success rates and theoretically a low incidence
of fetal abnormalities vs. follicular oocytes collected from
ovaries of aging females (see Figure 1).
More importantly, conventional IVF and assisted
reproduction technique (ART) can never accomplish the
provision of genetically related children in women lack-
ing the ability to produce their own follicular oocytes,
including young women rendered sterile after chemo-
therapy associated with oocyte loss and women with
POF. Autologous oocytes from OSC in culture have
been shown to produce blastocysts after fertilization
[202], and therefore could be used in subsequent IVF
and ART procedures.13. Why does menopause occur?
As indicated above, Ji Wu and colleagues have shown
that ovarian germline stem cell cultures derived from
5 day old and adult mouse ovaries infected with GFP
transgene produced functional oocytes when trans-
planted into ovaries of infertile mice. Such oocytes pro-
duced offspring expressing GFP of transplanted germline
stem cells [102]. The article confirms that OSC have the
capacity to produce meiotically potent and functional
oocytes in infertile mouse ovaries. This is also supported
by the human OSC culture studies, where some in vitro
developing oocytes differentiate into parthenogenetic
embryos [72,179,189,190].
13.1. A physiological role of ovarian stem cells in normal
ovaries
In a subsequent commentary [197] to the article of Ji
Wu and colleagues [102], several important questions
were raised regarding the in-vivo biology for ovarian
function and the relevance of this work to reproductive
health in women. Is there a physiological role of OSC in
normal ovaries? It has been suggested that although
these stem cells originated from normal ovaries, their
full germline potential may be the consequence of long
term culture and their oogenic activity normally sup-
pressed in vivo.
Regarding the oogenic activity of human OSC in nor-
mal ovaries, it is undoubtedly suppressed unless two
conditions are met (see Figure 9). Firstly, there should
be certain hormonal conditions accompanying the fetal
midgestation and adult periovulatory periods, such as
high circulating levels of estradiol and LH/hCG. Under
these conditions, however, only some ovarian stem cells
are converted into germ cells in vivo by asymmetric di-
vision due to the requirement of local cellular signaling
by immune system-related cells [68,134], (so-called im-
mune physiology of the mammalian ovary [203] or
immunoregulation of ovarian homeostasis [69]). Immu-
nohistochemistry of the immune system-related cells (T
cells and MDC) has shown that the emergence of germ
cells from OSC in vivo requires primitive MDC (CD14+)
and activated (HLA-DR+) CD8+ T cells. The emergence
of granulosa cells is accompanied by activated (HLA-DR+)
MDC [87,100,203]. Also, during adulthood, activated
MDC accompanies migration of germ cells from TA to
the ovarian cortex, where they enter ovarian vessels
11,87,100,203] (see Figure 8).
Transplantation of bone marrow cells restores fertility
in mice after chemotherapy-induced POF [204], possibly
due to the addition of immune system-related cells. It
appears, however, that the immune system-related cells
are not required for oogenesis from OSC in vitro. Hence
oogenic activity of ovarian stem cells seems to be inhi-
bited in vivo, unless appropriate hormonal and cellular
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Chapter 10).
13.2. Availability of granulosa cells
Survival and function of oocytes in vivo requires their
interaction with granulosa cells, and the number or ac-
tivity of granulosa cells may restrict the function of fe-
male germ cells [197]. Regarding granulosa cells, marked
differences exist between adult ovaries in different spe-
cies. In small laboratory rodents, granulosa cells origi-
nate from solid epithelial cords [3]. The ovarian structure
resembles human fetal ovaries with an abundance of
OSC-derived granulosa cells [100,135]. However, in adult
human ovaries during the prime reproductive period the
development of OSC-derived cortical nests of primitive
granulosa cells occurs [122,205]. Granulosa cell nests are
transported through dense ovarian stroma to the deep
cortex to assemble with newly formed oocytes provided
by vascular transport or migration from the adjacent cor-
tical OSC crypt [11]. Our observations also show that the
number of newly formed adult primordial follicles is
determined by the availability of granulosa cell nests. Su-
perfluous vascular oocytes degenerate in the medullary
venules [11,87,139].
After the prime reproductive period and in ovaries
with POF, however, degenerating intravascular oocytes
and ovarian cortical granulosa cell nests are virtually ab-
sent [94,134]. This indicates that the availability of trans-
planted germ cells in adult human ovaries lacking
granulosa cell nests may not be sufficient for follicular
renewal. Alternatively, transplantation of uncommitted
autologous OSC may be a source of both cell types
required for follicular renewal, the granulosa cell nests
and germ cells. Furthermore, transplantation of autolo-
gous committed germ cells may be accompanied by un-
committed autologous OSC, if available. Cultured
human OSC could be frozen for an extended storage
and future use [202].
The restoration of ovarian function in ovaries with ar-
tificially depleted oocytes [102] was successful probably
due to the preservation of the mouse ovarian stem cell
niche and the preserved granulosa cells. However, POF
in human females is supposedly caused by the pro-
grammed premature termination of the ovarian stem cell
niche function [9]. Many of such ovaries still carry OSC
but fail to renew their missing primordial follicles. Ma-
ture oocytes can, however, be produced by OSC culture
[12].
13.3. Why do ovarian stem cells not prevent menopause?
Another important query raised was that even if the ac-
tivity of ovarian stem cells in vivo is shown to replenish
follicular pool and is accepted, why do they fail to main-
tain ovarian function with advancing age [197]. Indeed,OSC from anovulatory and postmenopausal ovaries have
the capacity to differentiate in vitro into oocytes [94].
However, it has to be taken into account that the im-
mune system shows a significant functional decline be-
tween 35 and 40 years of age [150] and concomitantly
the ovarian follicular renewal ceases. Continuation of
ovarian function until the menopause is based on
utilization of aged primordial follicles previously formed
[11]. The age associated changes in the immune system
may be responsible for the termination of neo-oogenesis
and follicular renewal in vivo [87,132].
During development in human females, germ cells dif-
ferentiate much earlier during the embryonic period, as
compared to granulosa cells and fetal primordial folli-
cles, which appear during the second trimester of fetal
intrauterine life [112]. There is a striking correlation be-
tween the period at which organ components are
present during early ontogeny and that organ's func-
tional longevity [1]. It is likely that the lack of formation
of granulosa cells required for the formation of new
primordial follicles and the resulting cessation of ovarian
ovulatory function is central to the occurrence of the
menopause.
13.4. Perimenopausal disorders
During the perimenopausal period the risk of acute
myocardial infarction rises sharply, as well as hyperten-
sion and increased lipids and body weight, vascular
intima-media thickness, breast cancer risk, and aging
brain disorders, especially dementia and Parkinson's dis-
ease [206,207]. Differentiation of OSC is dependent on
the TCS ensuring tissue homeostasis. The lack of OSC
differentiation around 50 years of age (Table 2) suggest
that homeostasis is particularly altered at that time in
order to terminate any ovarian activity. Such perimeno-
pausal alteration of homeostasis may also induce disor-
ders of other tissues listed above.
14. Clinical trial
This chapter is an adapted version published as a
"Potential treatment of ovarian infertility" part of the
Ref. [94].
14.1. Differentiation of oocytes from OSC in vitro
Early in 2005, we established primary OSC cultures and
observed that OSC have a capacity to differentiate into
distinct somatic cell types (epithelial cells, fibroblasts,
granulosa, and neural type cells) and also oocytes [7].
The functional capacity of such OSC-derived oocytes is
confirmed by their development into parthenogenetic
embryos expressing DAZL protein - see Figure 16. Al-
though OSC originate from fetal mesothelial cells cover-
ing peritoneal cavity, the adult peritoneal mesothelial
cells do not have characteristics of stem cells as they
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represent a new adult stem cell type with unique toti-
potent features.
14.2. Potential treatment of ovarian infertility
The criteria for the utilization of OSC cultures in the
treatment of the female ovarian infertility was elaborated
[12] as follows.
14.3. Suitability of patients for clinical trial
Patients with the diagnosis of premature ovarian failure
(POF) may be included in the clinical trial. Optimally,
these patients failed to conceive due to a lack of their
own functional oocytes during previous standard IVF
therapy, or such therapy was impossible due to the lack
of oocytes within ovaries, and they are considering new
options to have a genetically related child before using
donated oocytes. Patients should provide a detailed
medical history and available laboratory results for con-
sideration in the trial. Ultrasound or MRI images of
ovaries should be done, and patients advised to utilize
certain hormonal therapies several weeks prior to the
procedure.
Prospective patients and their partners should not
carry any genetical alterations that can be transmitted to
the child. Of particular importance is the exclusion of
POF with the fragile X premutation (>200 CGG trinu-
cleotide repeats of FMR1 gene), since the birth of a child
in such women may result in mental retardation of the
progeny [208]. Genetic alterations are detected in a pro-
portion of patients with POF, particularly those with pri-
mary amenorrhea [157], and fragile X premutation was
detected in 4.8% of patients with POF [209]. Therefore,
evidence on the lack of a known genetic abnormality
should be provided, or the patients tested.
If needed, additional laboratory investigation from
blood and urine, as well as imaging procedures would be
done after admission. All considered women should have
a male partner with normal semen quality. Women with
infertile partners (i.e. with azoospermia) should be
excluded.
Therapy of ovarian infertility with cultured OSC
should be explained to the patient by a specialist in
gynecology and obstetrics, who is familiar with this new
technique. The medical documentation of each patient
and her male partner should be evaluated by an interdis-
ciplinary committee for in vitro fertilization, which
would approve inclusion into the trial. An institutional
review board (IRB) should approve the clinical trial.
14.4. Collection of ovarian stem cells and in vitro culture
of oocytes
Ovarian stem cells and small ovarian biopsies are col-
lected during laparoscopy. OSC and cells collected byscraping of tissue biopsies are cultured for 5 to 10 days
to determine whether or not they can produce oocytes.
If oocytes develop, they can be genetically analyzed. In
the future, they may be fertilized by classical IVF, or by
ICSI with the partner’s semen after approval of the Me-
dical Ethics Committee. Embryos, if developed, are cul-
tured to the blastocyst stage, and before transfer into the
uterus, evaluated by preimplantation genetic diagnosis.
Embryos may be cryopreserved. When a woman is hor-
monally prepared, at most two normal blastocysts can
be transferred into the uterus and supernumerary blasto-
cysts are cryopreserved for a potential later need of the
patient. In case of a pregnancy, amniocentesis should be
performed for genetic evaluation of the fetus.
14.5. Potential pitfalls
During the clinical trial, the following complications of
cultured cells could occur: oocytes could not develop,
oocytes could not be appropriate for fertilization,
oocytes could not be fertilized, fertilized oocytes could
not develop into embryos, or embryos could not be
transferred into the uterus because they were genetically
abnormal.
14.6. Initiation of the first clinical trial
Criteria for initiation of a clinical trial was found appro-
priate and its initiation in the IVF laboratory, Depart-
ment of Obstetrics and Gynecology, University Medical
Center Ljubljana, approved by the Slovenian Committee
for the Medical Ethics. Early in 2006, Dr. Antonin
Bukovsky (AB) and Dr. Irma Virant-Klun (IVK) met in
her IVF laboratory of the Department of Obstetrics and
Gynecology, University Medical Centre Ljubljana, Slo-
venia, to initiate the trial. The objective was to evaluate
if there are OSC in infertile women with POF, if they
contain putative stem cells, and if they can develop into
oocytes capable of fertilization in vitro. After informed
consent process, three patients with POF and no natur-
ally present oocytes in ovaries, aged 30, 38, and 40 years,
and their normospermic partners were selected.
Collection of the OSC was performed by Dr. Andrej
Vogler of the Department of Obstetrics and Gynecology,
University Medical Centre Ljubljana, 1000 Ljubljana,
Slovenia, in collaboration with AB and IVK. The cells
were collected during diagnostic laparoscopy by scratch-
ing the ovarian surface with scissors (Figure 19A) and
brush (Figure 19B), and ovarian biopsies (Figure 19 C
and D) were collected from both ovaries (see also Add-
itional file 3, supplemental video S2). The cells were col-
lected from the scissors and the brush into the culture
medium. Before the end of laparoscopy, the ovaries were
washed in reverse Trendelenburg position with 37°C
warm saline, and the liquid with cells was collected
from the cul-de-sac space. The collected liquid was
C D
BA
Figure 19 Snapshots from the collection of the OSC and ovarian biopsy from POF ovary by a laparoscopy. OSC are collected by
scratching the ovarian surface with scissors (arrows in A) and with a brush (arrow in B). Ovarian biopsies (C and D) are collected from each ovary.
For a complete video see Additional file 3, Video S2.
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in culture medium. From half of each biopsy and col-
lected OSC, the cell cultures were set up in DMEM/
F12 medium with phenol red (weak estrogenic action),
supplemented with antibiotics and 20% comprehen-
sively heat-inactivated serum (59°C, 60 minutes) of the
corresponding patient. The culture was monitored
daily.
Ovarian cells attached to the bottom of the dish began
to differentiate into epithelial and fibroblast cell types,
and some of them into oocytes. On day 3 of culture, the
initial medium was replaced with in vitro maturation
medium (Medicult IVM, Copenhagen, Denmark) supple-
mented with FSH (75mIU/ml), hCG (5 IU/ml) and 10%
heat-inactivated patient's serum. Prepared male partner's
sperm were added several hours later. Embryo-like
structures developed in the OSC cultures of two POF
women on the next day. They detached spontaneously
and were transferred into the wells with standard
medium for in vitro fertilization, where they developed
progressively to the morula-, preblastocyst- and
blastocyst-like structures. They were frozen to be later
genetically analyzed and transferred into the uterus, if
normal. Oocytes developed in vitro were analyzed genet-
ically and were shown to express genes related to
oocytes and pluripotent stem cells.
The remaining oocytes developed in vitro were ana-
lyzed genetically and were shown to express genes
related to oocytes and pluripotent stem cells.
Material from biopsies was investigated by immuno-
histochemistry for the presence of OSC and granulosacells of primary follicles (cytokeratin expression). No pri-
mary or other follicle types were found. Development of
oocytes and embryo-like structures after in vitro insem-
ination of cultures correlated with the presence of OSC
in the biopsies. In one woman with no OSC in both bi-
opsies no oocytes developed and embryo-like structures
were absent after utilization of in vitro maturation and
sperm [94].
Results of this research confirm the presence of OSC
stem cells in some infertile women with POF, which are
capable of developing into oocytes and be fertilized
in vitro. These observations indicate that adult human
ovaries are capable of producing new oocytes for follicu-
lar renewal. This fails to occur in vivo in POF patients.
Ovarian stem cultures offer a new chance for infertile
women with POF to have genetically related offspring,
and should be investigated further.15. Conclusions
In addition to its classically defined role in host
defenses, the immune system is integral to the differen-
tiation and maintenance of all normal tissues. Function
of distinct tissues during adulthood, including the
ovary, requires (1) Renewal from stem cells, (2) Preser-
vation of tissue-specific cells in a proper differentiated
state, and (3) Regulation of tissue quantity. Such mor-
phostasis can be executed by the TCS, consisting of
immune system-related components, vascular pericytes
and autonomic innervation. Morphostasis is established
epigenetically, during morphogenetic developmental immune
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Subsequently, the tissues are maintained in a state of
differentiation reached during the adaptation by a “stop
effect” of resident and self renewing MDC. Alteration of
certain tissue differentiation during the critical develop-
mental period causes persistent alteration of that tissue
function, including POF and primary amenorrhea.
Morphostasis is altered with advancing age, due to de-
generative changes of the immune system. Immune cells
and pericytes in fetal and adult human ovaries partici-
pate in: (1) follicular renewal during the prime repro-
ductive period, which includes the origin of new germ
cells by asymmetric division of OSC. This process is
more complex (formation of primitive granulosa cell
nests and vascular transport of new germ cells) than the
formation of secondary germ cells and adult primordial
follicles in fetal gonads, (2) Activated pericytes and
MDC accompany selection of growing follicles from the
adult primordial follicles present in ovaries, and (3)
Temporary retardation of thecal development and se-
lective support of granulosa cell maturation during large
antral follicle selection are required for resistance to
atresia.
Our studies have shown for the first time that in
addition to neo-oogenesis and follicular renewal in
human and rat females, human OSC are capable of dif-
ferentiating into functional oocytes, as indicated by their
ability to produce parthenogenetic embryos, including
OSC from POF and postmenopausal ovaries. Conven-
tional IVF with autologous follicular oocytes is usually
not utilized in women exceeding 40 years of age, due to
the high failure rate and fetal abnormalities. This is due to
the cessation of oocyte and follicular renewal at 38+/-2
years of age. In contrast, however, functional oocytes de-
velop de novo from OSC in culture regardless of age.
Therefore, they can be used for IVF in women exceeding
40 years of age without a risk of high failure rates and high
fetal abnormalities.
Most importantly, what conventional IVF and ART
cannot accomplish is to provide genetically related chil-
dren to women lacking the ability to produce their
own follicular oocytes, including young women ren-
dered sterile from chemotherapy associated with oocyte
loss, and women with POF. This may be solved by
clinical use of autologous oocytes from OSC in culture
in the future.
Ovarian stem cells are present in premenopausal
and postmenopausal women, with exception of the
narrow perimenopausal period (ages 49–52). This may
be caused by the overall alteration of tissue homeo-
stasis causing sharply increased risk of acute myocar-
dial infarction, hypertension, increased body weight,
vascular disorders, breast cancer, and aging brain
disorders.Additional files
Additional file 1: Video S1. Oocyte development after seeding of the
secondary OSC culture.
Additional file 2: Supplemental material (S1). Baas T: Repowering the
ovary. Science-Business eXchange 2012, 5:4-6.
Additional file 3: Video S2. Laparoscopic collection of OSC and
biopsies from POF ovaries.
Abbreviations
ART: Assisted reproduction techniques; CK: Cytokeratin; CL: Corpora lutea;
DAZL: Deleted azoospermia-like protein; DC: Dendritic cells; ESC: Embryonic
stem cells; HLA-DR: Class II major histocompatibility antigens; IVF: In-vitro
fertilization; MDC: Monocyte-derived cells; MHC-I: Major histocompatibility
class I heavy chain antigens; OSC: Ovarian stem cells; OSCs: Oogonial stem
cells; POF: Premature ovarian failure; SCP3: Synaptonemal complex protein-3;
TA: Tunica albuginea; TCS: tissue control system; Thy-1: Thy-1 differentiation
glycoprotein; ZP: Zona pellucida.
Competing interests
AB and MRC are listed as inventors of the United States Patent No.: 8,232,077
B2 dated Jul. 31, 2012, entitled "Oocytes derived from ovarian culture initially
containing no oocytes", and assigned to Ovacyte LLC (ovacyte.com).
Authors’ contributions
AB has written the manuscript draft and MRC contributed to its final version.
Both authors read and approved the final manuscript.
Acknowledgments
The authors wish to thank Drs. Irma Virant-Klun, Helena Meden-Vrtovec,
Andrej Vogler, Tomaz Tomazevic, and Jasna Sinkovec of the Department of
Obstetrics and Gynecology, University Medical Centre Ljubljana, 1000
Ljubljana, Slovenia, for their involvement in the first clinical trial experiments
and stimulating suggestions and support, as well as excellent laparoscopic
collection of OSC and ovarian biopsies by Dr. Andrej Vogler (who provided a
laparoscopic video presented here), as published in the "Potential treatment
of ovarian infertility" part and Acknowledgments in the 2006 chapter [94] -
reviewed in the Chapter 14 of this manuscript.
Author details
1The Institute of Biotechnology, Academy of Sciences of the Czech Republic,
Prague, Czech Republic. 2Cherokee Health Systems, 2018 Western Avenue,
Knoxville, Tennessee 37921, USA.
Received: 23 June 2012 Accepted: 11 November 2012
Published: 23 November 2012
16. References
1. Bukovsky A: Immune maintenance of self in morphostasis of distinct
tissues, tumor growth, and regenerative medicine. Scand J Immunol 2011,
73:159–189.
2. Simkins CS: Origin of the sex cells in man. Am J Anat 1928, 41:249–253.
3. Evans HM, Swezy O: Ovogenesis and the normal follicular cycle in adult
mammalia. Mem Univ Calif 1931, 9:119–224.
4. Jirasek JE: Paramesonephric epithelium and its relationship to the surface
epithelium of the ovary. Cesk Gynekol 1973, 38:691–694.
5. Bjersing L, Cajander S: Ovulation and the role of the ovarian surface
epithelium. Experientia 1975, 31:605–608.
6. Auersperg N, Siemens CH, Myrdal SE: Human ovarian surface epithelium
in primary culture. In Vitro 1984, 20:743–755.
7. Bukovsky A, Svetlikova M, Caudle MR: Oogenesis in cultures derived from
adult human ovaries. Reprod Biol Endocrinol 2005, 3:17. http://www.rbej.
com/content/3/1/17
8. Hayashi K, Ogushi S, Kurimoto K, Shimamoto S, Ohta H, Saitou M: Offspring
from Oocytes Derived from in Vitro Primordial Germ Cell-Like Cells in
Mice. Science 2012, .
9. Bukovsky A: Ovarian stem cell niche and follicular renewal in mammals.
Anat Rec (Hoboken ) 2011, 294:1284–1306.
Bukovsky and Caudle Reproductive Biology and Endocrinology 2012, 10:97 Page 41 of 45
http://www.rbej.com/content/10/1/9710. Telfer EE, Albertini DF: The quest for human ovarian stem cells. Nat Med
2012, 18:353–354.
11. Bukovsky A, Caudle MR, Svetlikova M, Upadhyaya NB: Origin of germ cells
and formation of new primary follicles in adult human ovaries. Reprod
Biol Endocrinol 2004, 2:20. http://www.rbej.com/content/2/1/20
12. Bukovsky A, Copas P, Virant-Klun I: Potential new strategies for the
treatment of ovarian infertility and degenerative diseases with
autologous ovarian stem cells. Expert Opin Biol Ther 2006, 6:341–365.
13. Nishizuka Y, Sakakura T: Thymus and reproduction: sex-linked dysgenesia
of the gonad after neonatal thymectomy in mice. Science 1969,
166:753–755.
14. Nishizuka Y, Sakakura T: Ovarian dysgenesis induced by neonatal
thymectomy in the mouse. Endocrinology 1971, 89:886–893.
15. Sakakura T, Nishizuka Y: Thymic control mechanism in ovarian
development: reconstitution of ovarian dysgenesis in thymectomized
mice by replacement with thymic and other lymphoid tissues.
Endocrinology 1972, 90:431–437.
16. Sakakura T, Nishizuka Y: Thymic control mechanism in ovarian
development: reconstitution of ovarian dysgenesis in thymectomized
mice by replacement with thymic and other lymphoid tissues.
Endocrinology 1972, 90:431–437.
17. Kincl FA, Oriol A, Folch Pi A, Maqueo M: Prevention of steroid-induced
sterility in neonatal rats with thymic cell suspension. Proc Soc Exp Biol
Med 1965, 120:252–255.
18. Russell WR, Walpole AL, Labhsetwar AP: Cyclophosphamide: induction of
superovulation in rats. Nature 1973, 241:129–130.
19. Hahn EW, Morales RL: Superpregnancy following prefertilization
X-irradiation of the rat. J Reprod Fertil 1964, 7:73–78.
20. Bukovsky A, Presl J, Krabec Z: Dealyed anovulatory syndrome after
long-lasting progesterone administration in early postnatal period in the
rat and its relation to follicular atresia. Cesk Gynekol 1976, 41:281–285.
21. Bukovsky A, Trebichavsky I, Presl J, Zidovsky J: Submicroscopic evidence of
lymphoid cells within the granulosa of the rat atretic follicle. IRCS Med Sci
1978, 6:80.
22. Bukovsky A, Presl J, Zidovsky J: Migration of lymphoid cells into the
granulosa of rat ovarian follicles. IRCS Med Sci 1979, 7:603–604.
23. Bukovsky A, Presl J, Holub M: Ovarian morphology in congenitally athymic
mice. Folia Biol (Praha) 1978, 24:442–443.
24. Bukovsky A, Presl J: Ovarian function and the immune system.
Med Hypotheses 1979, 5:415–436.
25. Pate JL, Toyokawa K, Walusimbi S, Brzezicka E: The Interface of the
Immune and Reproductive Systems in the Ovary: Lessons Learned from
the Corpus Luteum of Domestic Animal Models. Am J Reprod Immunol
2010, 64:275–286.
26. Espey LL: Ovulation as an inflammatory reaction–a hypothesis.
Biol Reprod 1980, 22:73–106.
27. Espey LL: Current status of the hypothesis that mammalian ovulation is
comparable to an inflammatory reaction. Biol Reprod 1994, 50:233–238.
28. Klein J: Immunology: The Science of Self-Nonself Discrimination. New York:
John Wiley and Sons, Inc; 1982.
29. Bukovsky A, Presl J, Zidovsky J, Mancal P: The localization of Thy-1.1, MRC
OX 2 and Ia antigens in the rat ovary and fallopian tube. Immunology
1983, 48:587–596.
30. Grim M, Bukovsky A: How closely are rat skeletal muscle development
and regeneration processes related? Bibl Anat 1986, 29:154–172.
31. Serre G, Vincent C, Viraben R, Soleilhavoup JP: Natural IgM and IgG
autoantibodies to epidermal keratins in normal human sera. I: ELISA-
titration, immunofluorescence study. J Invest Dermatol 1987, 88:21–27.
32. Avrameas S: Natural autoantibodies: from 'horror autotoxicus' to 'gnothi
seauton'. Immunol Today 1991, 12:154–159.
33. Barrett TA, Gajewski TF, Danielpour D, Chang EB, Beagley KW, Bluestone JA:
Differential function of intestinal intraepithelial lymphocyte subsets.
J Immunol 1992, 149:1124–1130.
34. Beagley KW, Husband AJ: Intraepithelial lymphocytes: origins, distribution,
and function. Crit Rev Immunol 1998, 18:237–254.
35. Yoon JW, Jun HS, Santamaria P: Cellular and molecular mechanisms for
the initiation and progression of beta cell destruction resulting from the
collaboration between macrophages and T cells. Autoimmunity 1998,
27:109–122.
36. Schranz DB, Lernmark A: Immunology in diabetes: an update. Diabetes
Metab Rev 1998, 14:3–29.37. Bukovsky A, Ayala ME, Dominguez R, Keenan JA, Wimalasena J, McKenzie PP,
Caudle MR: Postnatal androgenization induces premature aging of rat
ovaries. Steroids 2000, 65:190–205.
38. Bukovsky A, Caudle MR, Keenan JA: Dominant role of monocytes in
control of tissue function and aging. Med Hypotheses 2000, 55:337–347.
39. Havran WL, Jameson JM, Witherden DA: Epithelial cells and their
neighbors. III. Interactions between intraepithelial lymphocytes and
neighboring epithelial cells. Am J Physiol Gastrointest Liver Physiol 2005,
289:G627–G630.
40. Komori HK, Meehan TF, Havran WL: Epithelial and mucosal gammadelta T
cells. Curr Opin Immunol 2006, 18:534–538.
41. Havran WL, Jameson JM: Epidermal T cells and wound healing. J Immunol
2010, 184:5423–5428.
42. Macleod AS, Havran WL: Functions of skin-resident gammadelta T cells.
Cell Mol Life Sci 2011, 68:2399–2408.
43. Carrel A: Growth-promoting function of leukocytes. J Exp Med 1922,
36:385–391.
44. Fidler IJ: Lymphocytes are not only immunocytes. Biomedicine 1980,
32:1–3.
45. Yonish Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, May P,
Oren M: p53-mediated cell death: relationship to cell cycle control. Mol Cell
Biol 1993, 13:1415–1423.
46. Gonzalo JA, Baixeras E, Gonzalez-Garcia A, George-Chandy A, Van RN,
Martinez C, Kroemer G: Differential in vivo effects of a superantigen and
an antibody targeted to the same T cell receptor. Activation-induced cell
death vs passive macrophage-dependent deletion. J Immunol 1994,
152:1597–1608.
47. Nargi JL, Woodford-Thomas TA: Cloning and characterization of a cdc25
phosphatase from mouse lymphocytes. Immunogenetics 1994, 39:99–108.
48. Yamamoto M, Fujihashi K, Amano M, McGhee JR, Beagley KW, Kiyono H:
Cytokine synthesis and apoptosis by intestinal intraepithelial
lymphocytes: signaling of high density alpha beta T cell receptor+ and
gamma delta T cell receptor+ T cells via T cell receptor-CD3 complex
results in interferon-gamma and interleukin-5 production, while low
density T cells undergo DNA fragmentation. Eur J Immunol 1994,
24:1301–1306.
49. Reynisdottir I, Polyak K, Iavarone A, Massague J: Kip/Cip and Ink4 Cdk
inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Genes Dev 1995, 9:1831–1845.
50. Jorres A, Ludat K, Lang J, Sander K, Gahl GM, Frei U, DeJonge K, Williams JD,
Topley N: Establishment and functional characterization of human
peritoneal fibroblasts in culture: regulation of interleukin-6 production
by proinflammatory cytokines. J Am Soc Nephrol 1996, 7:2192–2201.
51. Saile B, Eisenbach C, El-Armouche H, Neubauer K, Ramadori G:
Antiapoptotic effect of interferon-alpha on hepatic stellate cells (HSC): a
novel pathway of IFN-alpha signal transduction via Janus kinase 2 (JAK2)
and caspase-8. Eur J Cell Biol 2003, 82:31–41.
52. Fischer AN, Herrera B, Mikula M, Proell V, Fuchs E, Gotzmann J, Schulte-
Hermann R, Beug H, Mikulits W: Integration of Ras subeffector signaling in
TGF-beta mediated late stage hepatocarcinogenesis. Carcinogenesis 2005,
26:931–942.
53. Li X, Lu Y, Huang W, Xu H, Chen X, Geng Q, Fan H, Tan Y, Xue G, Jiang X: In
vitro effect of adenovirus-mediated human Gamma Interferon gene
transfer into human mesenchymal stem cells for chronic myelogenous
leukemia. Hematol Oncol 2006, 24:151–158.
54. Campanaro S, Picelli S, Torregrossa R, Colluto L, Ceol M, Del PD, D'Angelo A,
Valle G, Anglani F: Genes involved in TGF beta1-driven epithelial-
mesenchymal transition of renal epithelial cells are topologically related
in the human interactome map. BMC Genomics 2007, 8:383.
55. Fu X, He Y, Xie C, Liu W: Bone marrow mesenchymal stem cell
transplantation improves ovarian function and structure in rats with
chemotherapy-induced ovarian damage. Cytotherapy 2008, 10:353–363.
56. Bierie B, Moses HL: Transforming growth factor beta (TGF-beta) and
inflammation in cancer. Cytokine Growth Factor Rev 2010, 21:49–59.
57. Ramasamy R, Tong CK, Yip WK, Vellasamy S, Tan BC, Seow HF: Basic
fibroblast growth factor modulates cell cycle of human umbilical
cord-derived mesenchymal stem cells. Cell Prolif 2012, 45:132–139.
58. Luo H, Zhang Y, Zhang Z, Jin Y: The protection of MSCs from apoptosis in
nerve regeneration by TGFbeta1 through reducing inflammation and
promoting VEGF-dependent angiogenesis. Biomaterials 2012,
33:4277–4287.
Bukovsky and Caudle Reproductive Biology and Endocrinology 2012, 10:97 Page 42 of 45
http://www.rbej.com/content/10/1/9759. Bukovsky A, Presl J, Krabec Z, Bednarik T: Ovarian function in adult rats
treated with antithymocyte serum. Experientia 1977, 33:280–281.
60. Bukovsky A, Presl J, Krabec Z: Effects of postnatal progesterone treatment
on ovarian function in adult rats. Experientia 1979, 35:562–563.
61. Bukovsky A, Presl J, Holub M: The role of the immune system in ovarian
function control. Allergol Immunopathol 1981, 9:447–456.
62. Bukovsky A, Presl J, Holub M, Mancal P, Krabec Z: The localization of
brain-thymus shared antigen (Thy-1) and thymosin 5 within the adult rat
ovary. IRCS Med Sci 1982, 10:69–70.
63. Bukovsky A, Michael SD, Presl J: Cell-mediated and neural control of
morphostasis. Med Hypotheses 1991, 36:261–268.
64. Bukovsky A, Caudle MR, Keenan JA, Wimalasena J, Foster JS, Van Meter SE:
Quantitative evaluation of the cell cycle-related retinoblastoma protein
and localization of Thy-1 differentiation protein and macrophages
during follicular development and atresia, and in human corpora lutea.
Biol Reprod 1995, 52:776–792.
65. Bukovsky A, Caudle MR, Keenan JA: Regulation of ovarian function by
immune system components: the tissue control system (TCS). In
Microscopy of Reproduction and Development: A Dynamic Approach. Edited
by Motta PM. Roma: Antonio Delfino Editore; 1997:79–89.
66. Bukovsky A, Caudle MR: Immunology: animal models. In Encyclopedia of
Aging. Edited by Ekerdt DJ. New York: Macmillan Reference USA;
2002:691–695.
67. Bukovsky A, Ayala ME, Dominguez R, Keenan JA, Wimalasena J, Elder RF,
Caudle MR: Changes of ovarian interstitial cell hormone receptors and
behavior of resident mesenchymal cells in developing and adult rats
with steroid-induced sterility. Steroids 2002, 67:277–289.
68. Bukovsky A: Cell commitment by asymmetric division and immune
system involvement. Prog Mol Subcell Biol 2007, 45:179–204.
69. Bukovsky A, Gupta SK, Svetlikova M, White RS, Copas P, Upadhyaya NB, Van
Meter SE: Immunoregulation of ovarian homeostasis. In Novel Concepts in
Ovarian Endocrinology. Edited by Gonzalez-Bulnes A. Kerala, India: Research
Signpost; 2008:131–168.
70. Bukovsky A, Caudle MR, Svetlikova M: Steroid-mediated differentiation of
neural/neuronal cells from epithelial ovarian precursors in vitro. Cell Cycle
2008, 7:3577–3583.
71. Bukovsky A, Caudle MR, Carson RJ, Gaytan F, Huleihel M, Kruse A, Schatten H,
Telleria CM: Immune physiology in tissue regeneration and aging, tumor
growth, and regenerative medicine. Aging 2009, 1:157–181.
72. Bukovsky A, Caudle MR, Virant-Klun I, Gupta SK, Dominguez R, Svetlikova M,
Xu F: Immune physiology and oogenesis in fetal and adult humans,
ovarian infertility, and totipotency of adult ovarian stem cells. Birth
Defects Res C Embryo Today 2009, 87:64–89.
73. Hillier SG, Zeleznik AJ, Knazek RA, Ross GT: Hormonal regulation of
preovulatory follicle maturation in the rat. J Reprod Fertil 1980,
60:219–229.
74. Dominguez R, Zipitria D, Aguilar L, Riboni L: Effects of unilateral
destruction of the cervico-vaginal plexus on ovulation in the rat.
J Endocrinol 1981, 91:483–486.
75. Nakamura Y, Kato H, Terranova PF: Abdominal vagotomy decreased the
number of ova shed and serum progesterone levels on estrus in the
cyclic hamster. Endocrinol Jpn 1992, 39:141–145.
76. Chryssikopoulos A: The relationship between the immune and endocrine
systems. Ann N Y Acad Sci 1997, 816:83–93.
77. Vinatier D, Dufour P, Tordjeman-Rizzi N, Prolongeau JF, Depret-Moser S,
Monnier JC: Immunological aspects of ovarian function: role of the
cytokines. Eur J Obstet Gynecol Reprod Biol 1995, 63:155–168.
78. Allen E: Ovogenesis during sexual maturity. Am J Anat 1923, 31:439–481.
79. Pearl R, Schoppe WF: Studies on the physiology of reproduction in the
domestic fowl. XVIII. Further observations on the anatomical basis of
fecundity. J Exp Zool 1921, 34:101–189.
80. Zuckerman S: The number of oocytes in the mature ovary. Recent Prog
Horm Res 1951, 6:63–109.
81. Franchi LL, Mandl AM, Zuckerman S: The development of the ovary and
the process of oogenesis. In The Ovary. Edited by Zuckerman S. London:
Academic Press; 1962:1–88.
82. Zuckerman S, Baker TG: The development of the ovary and the process of
oogenesis. In The Ovary, Volume I. Edited by Zuckerman S, Weir BJ.
New York: Academic Press; 1977:41–67.
83. Kingery HM: Oogenesis in the white mouse. J Morphol 1917,
30:261–315.84. Gerard P: Contribution a l'etude de l'ovarie des mammiferes. L'ovaire de
Galago mossambicus (Young). Arch Biol 1920, 43:357–391.
85. Rao CRN: On the structure of the ovary and the ovarian ovum of Loris
lydekkerianus Cabr. Qaurt J Micr Sci 1928, 71:57–73.
86. Zuckerman S, Weir BJ: The Ovary. Second Edition, Volume I. New York:
Academic Press; 1977.
87. Bukovsky A, Keenan JA, Caudle MR, Wimalasena J, Upadhyaya NB, Van
Meter SE: Immunohistochemical studies of the adult human ovary:
possible contribution of immune and epithelial factors to
folliculogenesis. Am J Reprod Immunol 1995, 33:323–340.
88. Bukovsky A, Bukovsky A: Human oogenesis and follicular renewal from
ovarian somatic stem cells. In Stem Cell Research Developments, Bukovsky a.
Edited by Fong CA. Hauppauge, NY: Nova Science Publishers, Inc;
2007:229–272.
89. Block E: Quantitative morphological investigations of the follicular
system in women. Variations at different ages. Acta Anat (Basel) 1952,
14:108–123.
90. Kerr JB, Duckett R, Myers M, Britt KL, Mladenovska T, Findlay JK:
Quantification of healthy follicles in the neonatal and adult mouse
ovary: evidence for maintenance of primordial follicle supply.
Reproduction 2006, 132:95–109.
91. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL: Germline stem cells and
follicular renewal in the postnatal mammalian ovary. Nature 2004,
428:145–150.
92. Ingram DL: Atresia. In The Ovary. Edited by Zuckerman S. London:
Academic Press; 1962:247–273.
93. Gougeon A, Echochard R, Thalabard JC: Age-related changes of the
population of human ovarian follicles: increase in the disappearance rate
of non-growing and early- growing follicles in aging women. Biol Reprod
1994, 50:653–663.
94. Bukovsky A, Virant-Klun I: Adult stem cells in the human ovary. In Stem
Cells in Reproductive Medicine: Basic Science & Therapeutic Potential. Edited by
Simon C, Pellicer A. London: Informa Healthcare; 2007:53–69.
95. Ioannou JM: Oogenesis in adult prosimians. J Embryol Exp Morphol 1968,
17:139–145.
96. van DM, Polman JE, De B,I, van GK, Bunschoten H, Grootenhuis A, Brindle J,
Aitken RJ: Recombinant human zona pellucida protein ZP3 produced by
chinese hamster ovary cells induces the human sperm acrosome
reaction and promotes sperm-egg fusion. Biol Reprod 1994, 51:607–617.
97. Ding J, Rana N, Dmowski WP: Intracytoplasmic sperm injection into zona-
free human oocytes results in normal fertilization and blastocyst
development. Hum Reprod 1999, 14:476–478.
98. Balaban B, Urman B, Sertac A, Alatas C, Aksoy S, Mercan R: Oocyte
morphology does not affect fertilization rate, embryo quality and
implantation rate after intracytoplasmic sperm injection. Hum Reprod
1998, 13:3431–3433.
99. Senger S, Csokmay J, Tanveer A, Jones TI, Sengupta P, Lilly MA: The
nucleoporin Seh1 forms a complex with Mio and serves an essential
tissue-specific function in Drosophila oogenesis. Development 2011,
138:2133–2142.
100. Bukovsky A, Caudle MR, Svetlikova M, Wimalasena J, Ayala ME, Dominguez R:
Oogenesis in adult mammals, including humans: a review. Endocrine 2005,
26:301–316.
101. Allen E, Creadick RN: Ovogenesis during sexual maturity, the first stage,
mitosis in the germinal epithelium, as shown by the colchicine
technique. Anat Rec 1937, 69:191–195.
102. Zou K, Yuan Z, Yang Z, Luo H, Sun K, Zhou L, Xiang J, Shi L, Yu Q, Zhang Y,
et al: Production of offspring from a germline stem cell line derived from
neonatal ovaries. Nat Cell Biol 2009, 11:631–636.
103. White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL: Oocyte formation
by mitotically active germ cells purified from ovaries of reproductive-age
women. Nat Med 2012, 18:413–421.
104. Baas T: Repowering the ovary. Science-Business eXchange 2012, 5:4–6.
105. Clark AT, Bodnar MS, Fox M, Rodriquez RT, Abeyta MJ, Firpo MT, Pera RA:
Spontaneous differentiation of germ cells from human embryonic stem
cells in vitro. Hum Mol Genet 2004, 13:727–739.
106. Cauffman G, Van d V, Liebaers I, Van SA: DAZL expression in human
oocytes, preimplantation embryos and embryonic stem cells. Mol Hum
Reprod 2005, 11:405–411.
107. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P: Molecular Biology
of the Cell. New York: Garland Science; 2002.
Bukovsky and Caudle Reproductive Biology and Endocrinology 2012, 10:97 Page 43 of 45
http://www.rbej.com/content/10/1/97108. Kelly SJ: Studies of the developmental potential of 4- and 8-cell stage
mouse blastomeres. J Exp Zool 1977, 200:365–376.
109. Ginsburg M, Snow MH, McLaren A: Primordial germ cells in the mouse
embryo during gastrulation. Development 1990, 110:521–528.
110. Lawson KA, Hage WJ: Clonal analysis of the origin of primordial germ
cells in the mouse. Ciba Found Symp 1994, 182:68–84.
111. Tam PP, Zhou SX: The allocation of epiblast cells to ectodermal and
germ-line lineages is influenced by the position of the cells in the
gastrulating mouse embryo. Dev Biol 1996, 178:124–132.
112. Peters H, McNatty KP: The Ovary. A Correlation of Structure and Function in
Mammals. Berkeley and Los Angeles, California: University of California Press;
1980.
113. Castrillon DH, Quade BJ, Wang TY, Quigley C, Crum CP: The human VASA
gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci
U S A 2000, 97:9585–9590.
114. Simkins CS: Development of the human ovary from birth to sexual
maturity. J Anat 1932, 51:465–505.
115. Motta PM, Makabe S: Development of the ovarian surface and associated
germ cells in the human fetus. Cell Tissue Res 1982, 226:493–510.
116. Motta PM, Makabe S: Germ cells in the ovarian surface during fetal
development in humans. A three-dimensional microanatomical study by
scanning and transmission electron microscopy. J Submicrosc Cytol 1986,
18:271–290.
117. Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ,
Lund-Johansen F: Dendritic cell ontogeny: a human dendritic cell lineage
of myeloid origin. Proc Natl Acad Sci U S A 1997, 94:12551–12556.
118. Byskov AG, Skakkebaek NE, Stafanger G, Peters H: Influence of ovarian
surface epithelium and rete ovarii on follicle formation. J Anat 1977,
123:77–86.
119. Van Wagenen G, Simpson ME: Embryology of the ovary and testis Homo
sapiens and Macaca mulatta. New Haven: Yale University Press; 1965.
120. Everett NB: Observational and experimental evidences relating to the
origin and differentiation of the definite germ cells in mice. J Exp Zool
1943, 92:49–91.
121. Brambell FWR: The development and morphology of the gonads of the
mouse. Part 1. The morphogenesis of the indifferent gonad and of the
ovary. Proc Roy Soc 1927, 101:391–409.
122. Motta PM, Van Blerkom J, Makabe S: Changes in the surface morphology
of ovarian 'germinal' epithelium during the reproductive cycle and in
some pathological conditions. J Submicrosc Cytol 1980, 12:407–425.
123. Sawyer HR, Smith P, Heath DA, Juengel JL, Wakefield SJ, McNatty KP:
Formation of ovarian follicles during fetal development in sheep.
Biol Reprod 2002, 66:1134–1150.
124. Bousfield GR, Butnev VY, Gotschall RR, Baker VL, Moore WT: Structural
features of mammalian gonadotropins. Mol Cell Endocrinol 1996, 125:3–19.
125. Bukovsky A: Mesenchymal cells in tissue homeostasis and cancer. Mod
Asp Immunobiol 2000, 1:43–47.
126. Bukovsky A, Caudle MR, Keenan JA, Upadhyaya NB, Van Meter S,
Wimalasena J, Elder RF: Association of mesenchymal cells and
immunoglobulins with differentiating epithelial cells. BMC Dev Biol 2001,
1:11. http://www.biomedcentral.com/1471-213X/1/11
127. Swift CH: Origin and early history of the primordial germ-cells of the
chick. Am J Anat 1914, 15:483–516.
128. Reagan FP: Some results and possibilities of early embryonic castration.
Anat Rec 1916, 11:251–267.
129. Lillie FR: The development of the chick. New York: Henry Holt & Co; 1908.
130. Baker TG: Oogenesis and ovarian development. In Reproductive
Biology. Edited by Balin H, Glasser S. Amsterdam: Excerpta Medica;
1972:398–437.
131. Yao HH, DiNapoli L, Capel B: Meiotic germ cells antagonize mesonephric
cell migration and testis cord formation in mouse gonads. Development
2003, 130:5895–5902.
132. Bukovsky A: Oogenesis from human somatic stem cells and a role of
immune adaptation in premature ovarian failure. Curr Stem Cell Res Ther
2006, 1:289–303.
133. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC: Ovarian surface
epithelium: biology, endocrinology, and pathology. Endocr Rev 2001,
22:255–288.
134. Bukovsky A: Immune system involvement in the regulation of
ovarian function and augmentation of cancer. Microsc Res Tech 2006,
69:482–500.135. Bukovsky A, Ayala ME, Dominguez R, Svetlikova M, Selleck-White R: Bone
marrow derived cells and alternative pathways of oogenesis in adult
rodents. Cell Cycle 2007, 6:2306–2309.
136. Motta PM, Makabe S, Naguro T, Correr S: Oocyte follicle cells association
during development of human ovarian follicle. A study by high
resolution scanning and transmission electron microscopy. Arch Histol
Cytol 1994, 57:369–394.
137. Liu Y, Wu C, Lyu Q, Yang D, Albertini DF, Keefe DL, Liu L: Germline stem
cells and neo-oogenesis in the adult human ovary. Dev Biol 2007,
306:112–120.
138. Tilly JL, Johnson J: Recent arguments against germ cell renewal in the
adult human ovary: Is an absence of marker gene expression really
acceptable evidence of an absence of oogenesis? Cell Cycle 2007,
6:879–883.
139. Bukovsky A, Caudle MR, Gupta SK, Svetlikova M, Selleck-White R, Ayala ME,
Dominguez R: Mammalian neo-oogenesis and expression of meiosis-
specific protein SCP3 in adult human and monkey ovaries. Cell Cycle
2008, 7:683–686.
140. Tres LL: XY chromosomal bivalent: nucleolar attraction. Mol Reprod Dev
2005, 72:1–6.
141. Faddy MJ: Follicle dynamics during ovarian ageing. Mol Cell Endocrinol
2000, 163:43–48.
142. Niikura Y, Niikura T, Tilly JL: Aged mouse ovaries possess rare premeiotic
germ cells that can generate oocytes following transplantation into a
young host environment. Aging (Albany NY) 2009, 1:971–978.
143. Kay MM: An overview of immune aging. Mech Ageing Dev 1979,
9:39–59.
144. Talbert GB: Effect of maternal age on reproductive capacity. Am J Obstet
Gynecol 1968, 102:451–477.
145. Kirkwood TB: Ovarian ageing and the general biology of senescence.
Maturitas 1998, 30:105–111.
146. Balfour BM, Drexhage HA, Kamperdijk EW, Hoefsmit EC: Antigen-presenting
cells, including Langerhans cells, veiled cells and interdigitating cells.
Ciba Found Symp 1981, 84:281–301.
147. Hoefsmit EC, Duijvestijn AM, Kamperdijk EW: Relation between Langerhans
cells, veiled cells, and interdigitating cells. Immunobiology 1982,
161:255–265.
148. Knight SC, Farrant J, Bryant A, Edwards AJ, Burman S, Lever A, Clarke J,
Webster AD: Non-adherent, low-density cells from human peripheral
blood contain dendritic cells and monocytes, both with veiled
morphology. Immunology 1986, 57:595–603.
149. Howard CJ, Hope JC: Dendritic cells, implications on function from
studies of the afferent lymph veiled cell. Vet Immunol Immunopathol
2000, 77:1–13.
150. Mathe G: Immunity aging. I. The chronic perduration of the thymus
acute involution at puberty? Or the participation of the lymphoid organs
and cells in fatal physiologic decline? Biomed Pharmacother 1997,
51:49–57.
151. Rebar RW: The thymus gland and reproduction: do thymic peptides
influence the reproductive lifespan in females? J Am Geriatr Soc 1982,
30:603–606.
152. Suh BY, Naylor PH, Goldstein AL, Rebar RW: Modulation of thymosin beta
4 by estrogen. Am J Obstet Gynecol 1985, 151:544–549.
153. Lintern Moore S, Pantelouris EM: Ovarian development in athymic nude
mice. The size and composition of the follicle population. Mech Ageing
Dev 1975, 4:385–390.
154. Lo PA, Ruvolo G, Gancitano RA, Cittadini E: Ovarian function following
radiation and chemotherapy for cancer. Eur J Obstet Gynecol Reprod Biol
2004, 113(Suppl 1):S33–S40.
155. Hoek A, van Kasteren Y, de Haan-Meulman M, Schoemaker J, Drexhage HA:
Dysfunction of monocytes and dendritic cells in patients with premature
ovarian failure. Am J Reprod Immunol 1993, 30:207–217.
156. Hoek A, van Kasteren Y, de Haan-Meulman M, Hooijkaas H, Schoemaker J,
Drexhage HA: Analysis of peripheral blood lymphocyte subsets, NK cells,
and delayed type hypersensitivity skin test in patients with premature
ovarian failure. Am J Reprod Immunol 1995, 33:495–502.
157. Rebar RW: Premature ovarian failure. In Menopause Biology and
Pathobiology. Edited by Lobo RA, Kesley J, Marcus R. San Diego: Academic
Press; 2000:135–146.
158. Edassery SL, Shatavi SV, Kunkel JP, Hauer C, Brucker C, Penumatsa K, Yu Y,
Dias JA, Luborsky JL: Autoantigens in ovarian autoimmunity associated
Bukovsky and Caudle Reproductive Biology and Endocrinology 2012, 10:97 Page 44 of 45
http://www.rbej.com/content/10/1/97with unexplained infertility and premature ovarian failure. Fertil Steril
2010, 94:2636–2641.
159. Kumar M, Pathak D, Venkatesh S, Kriplani A, Ammini AC, Dada R:
Chromosomal abnormalities & oxidative stress in women with
premature ovarian failure (POF). Indian J Med Res 2012, 135:92–97.
160. Bukovsky A, Caudle MR, Keenan JA, Wimalasena J, Upadhyaya NB, Van
Meter SE: Is corpus luteum regression an immune-mediated event?
Localization of immune system components, and luteinizing hormone
receptor in human corpora lutea. Biol Reprod 1995, 53:1373–1384.
161. Nagasawa H, Yanai R, Kikuyama S, Mori J: Pituitary secretion of prolactin,
luteinizing hormone and follicle-stimulating hormone in adult female
rats treated neonatally with oestrogen. J Endocrinol 1973, 59:599–604.
162. Matsumoto A, Asai T, Wakabayashi K: Effects of x-ray irradiation on the
subsequent gonadotropin secretion in normal and neonatally
estrogenized female rats. Endocrinol Jpn 1975, 22:233–241.
163. Deshpande RR, Chapman JC, Michael SD: The anovulation in female mice
resulting from postnatal injections of estrogen is correlated with altered
levels of CD8+ lymphocytes. Am J Reprod Immunol 1997, 38:114–120.
164. Swanson HE, van der Werff t, Bosch JJ: The "early-androgen" syndrome;
differences in response to prenatal and postnatal administration of
various doses of testosterone propionate in female and male rats. Acta
Endocrinol (Copenh) 1964, 47:37–50.
165. Coghlan A: Doubts cast over 'eggs on tap'. New Scientist 2005, 2499:13.
166. Nussbaum M: Zur Differenzierung des Geschlechts im Terreich. Arch
mikrosk Anat EntwMech 1880, 18:121–131.
167. Telfer EE: Germline stem cells in the postnatal mammalian ovary: A
phenomenon of prosimian primates and mice? Reprod Biol Endocrinol
2004, 2:24.
168. Gougeon A: Is neo-oogenesis in the adult ovary, a realistic paradigm?
Gynecol Obstet Fertil 2010, 38:398–401.
169. Parte SC, Bhartiya D, Telang J, Daithankar VV, Salvi V, Zaveri K, Hinduja I:
Detection Characterization and Spontaneous Differentiation in vitro of Very
Small Embryonic-like Putative Stem Cells in Adult Mammalian Ovary: Stem
Cells Dev; 2011.
170. Johnson J, Bagley J, Skaznik-Wikiel M, Lee HJ, Adams GB, Niikura Y, Tschudy KS,
Tilly JC, Cortes ML, Forkert R, et al: Oocyte generation in adult mammalian
ovaries by putative germ cells in bone marrow and peripheral blood.
Cell 2005, 122:303–315.
171. Kirby ML, Bockman DE: Neural crest and normal development: a new
perspective. Anat Rec 1984, 209:1–6.
172. Bockman DE, Kirby ML: Dependence of thymus development on
derivatives of the neural crest. Science 1984, 223:498–500.
173. McNatty KP, Heath DA, Henderson KM, Lun S, Hurst PR, Ellis LM,
Montgomery GW, Morrison L, Thurley DC: Some aspects of thecal and
granulosa cell function during follicular development in the bovine
ovary. J Reprod Fertil 1984, 72:39–53.
174. Morley P, Armstrong DT, Calaresu FR: Ovarian nerve extracts influence
androgen production by cultured ovarian thecal cells. Neuroendocrinology
1989, 50:93–99.
175. Morley P, Armstrong DT, Calaresu FR: Site at which ovarian nerve extracts
inhibit thecal androgen production. Mol Cell Endocrinol 1990, 71:33–40.
176. Bukovsky A, Caudle MR, Keenan JA, Wimalasena J, Upadhyaya NB, Van
Meter SE: Is irregular regression of corpora lutea in climacteric women
caused by age-induced alterations in the "tissue control system"? Am J
Reprod Immunol 1996, 36:327–341.
177. Mossman HW, Duke KL: Some comparative aspects of the mammalian
ovary. In Handbook of Physiology, Sect. 7: Endocrinology. Edited by Greep RO.
Washington: Am. Physiol. Soc; 1973:389–402.
178. Bukovsky A: Origin of germ cells and follicular renewal in adult human ovaries.
Presented at microscopy & microanalysis conference 2005 - July 31 - august 4,
Honolulu, Hawaii (invited); 2005 (Abstract).
179. Bukovsky A: Ovarian stem cells and mammalian neo-oogenesis. Microsc
Microanal 2008, 14(Suppl 2):1474–1475.
180. McNatty KP, Makris A, DeGrazia C, Osathanondh R, Ryan KJ: The production
of progesterone, androgens, and estrogens by granulosa cells, thecal
tissue, and stromal tissue from human ovaries in vitro. J Clin Endocrinol
Metab 1979, 49:687–699.
181. McNatty KP, Makris A, Osathanondh R, Ryan KJ: Effects of luteinizing
hormone on steroidogenesis by thecal tissue from human ovarian
follicles in vitro. Steroids 1980, 36:53–63.182. Nelson LR, Bulun SE: Estrogen production and action. J Am Acad Dermatol
2001, 45:S116–S124.
183. Blaustein A, Kaganowicz A, Wells J: Tumor markers in inclusion cysts of
the ovary. Cancer 1982, 49:722–726.
184. Martinez ML, Fontenot GK, Harris JD: The expression and localization of
zona pellucida glycoproteins and mRNA in cynomolgus monkeys
(Macaca fascicularis). J Reprod Fertil Suppl 1996, 50:35–41.
185. Prasad SV, Skinner SM, Carino C, Wang N, Cartwright J, Dunbar BS: Structure
and function of the proteins of the mammalian Zona pellucida.
Cells Tissues Organs 2000, 166:148–164.
186. Santos TA, Dias C, Henriques P, Brito R, Barbosa A, Regateiro F, Santos AA:
Cytogenetic analysis of spontaneously activated noninseminated
oocytes and parthenogenetically activated failed fertilized human
oocytes–implications for the use of primate parthenotes for stem cell
production. J Assist Reprod Genet 2003, 20:122–130.
187. Pepling ME, Spradling AC: Female mouse germ cells form synchronously
dividing cysts. Development 1998, 125:3323–3328.
188. Pepling ME, Spradling AC: Mouse ovarian germ cell cysts undergo
programmed breakdown to form primordial follicles. Dev Biol 2001,
234:339–351.
189. Virant-Klun I, Zech N, Rozman P, Vogler A, Cvjeticanin B, Klemenc P, Malicev
E, Meden-Vrtovec H: Putative stem cells with an embryonic character
isolated from the ovarian surface epithelium of women with no
naturally present follicles and oocytes. Differentiation 2008, 76(8):843–856.
190. Virant-Klun I, Rozman P, Cvjeticanin B, Vrtacnik-Bokal E, Novakovic S,
Ruelicke T: Parthenogenetic Embryo-Like Structures in the Human
Ovarian Surface Epithelium Cell Culture in Postmenopausal Women
with No Naturally Present Follicles and Oocytes. Stem Cells Dev 2009,
18(1):137–150.
191. Virant-Klun I, Skutella T: Stem cells in aged mammalian ovaries. Aging
(Albany NY) 2010, 2:3–6.
192. Bukovsky A: How Can Female Germline Stem Cells Contribute to the
Physiological Neo-Oogenesis in Mammals and Why Menopause Occurs?
Microsc Microanal 2011, 17:498–505.
193. Gosden RG: Transplantation of fetal germ cells. J Assist Reprod Genet 1992,
9:118–123.
194. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF: Accelerated
disappearance of ovarian follicles in mid-life: implications for forecasting
menopause. Hum Reprod 1992, 7:1342–1346.
195. Nandedkar T, Narkar M: Stem cell research: its relevance to reproductive
biology. Indian J Exp Biol 2003, 41:724–739.
196. Oatley J, Hunt PA: Of mice and (wo)men: purified oogonial stem cells
from mouse and human ovaries. Biol Reprod 2012, 86:196.
197. Tilly JL, Telfer EE: Purification of germline stem cells from adult
mammalian ovaries: a step closer towards control of the female
biological clock? Mol Hum Reprod 2009, 15:393–398.
198. Bukovsky A, Gupta SK, Bansal P, Chakravarthy S, Chaudhary M, Svetlikova M,
White RS, Copas P, Upadhyaya NB, Van Meter SE, et al: Production of
monoclonal antibodies against recombinant human zona pellucida
glycoproteins: utility in immunolocalization of respective zona proteins
in ovarian follicles. J Reprod Immunol 2008, 78:102–114.
199. Virant-Klun I, Skutella T, Stimpfel M, Sinkovec J: Ovarian surface epithelium
in patients with severe ovarian infertility: a potential source of cells
expressing markers of pluripotent/multipotent stem cells. J Biomed
Biotechnol 2011, 2011:381928.
200. Bukovsky A: Follicular renewal and age-related changes in ovaries.
NIH/NIA Grant Application: 1 R01 AG028003-01 2005, :27–59.
201. Luke B, Brown MB, Wantman E, Lederman A, Gibbons W, Schattman GL,
Lobo RA, Leach RE, Stern JE: Cumulative birth rates with linked assisted
reproductive technology cycles. N Engl J Med 2012, 366:2483–2491.
202. Bukovsky A, Virant-Klun I, Svetlikova M, Willson I: Ovarian germ cells.
Methods Enzymol 2006, 419:208–258.
203. Bukovsky A, Caudle MR: Immune physiology of the mammalian ovary - a
review. Am J Reprod Immunol 2008, 59:12–26.
204. Lee HJ, Selesniemi K, Niikura Y, Niikura T, Klein R, Dombkowski DM, Tilly JL:
Bone marrow transplantation generates immature oocytes and rescues
long-term fertility in a preclinical mouse model of chemotherapy-
induced premature ovarian failure. J Clin Oncol 2007, 25:3198–3204.
205. Van Blerkom J, Motta PM: The Cellular Basis of Mammalian Reproduction.
Baltimore-Munich: Urban & Schwarzenberg; 1979.
Bukovsky and Caudle Reproductive Biology and Endocrinology 2012, 10:97 Page 45 of 45
http://www.rbej.com/content/10/1/97206. Olszanecka A, Posnik-Urbanska A, Kawecka-Jaszcz K, Czarnecka D:
Subclinical organ damage in perimenopausal women with essential
hypertension. Pol Arch Med Wewn 2010, 120:390–398.
207. Cuzick J, Glasier A, La Vecchia C, Maraganore DM, Negri E, Rossi M, Spector T,
Trichopoulos D, van Baak MA, Zocchetti C, et al: Perimenopausal risk factors
and future health. Hum Reprod Update 2011, 17:706–717.
208. Corrigan EC, Raygada MJ, Vanderhoof VH, Nelson LM: A woman with
spontaneous premature ovarian failure gives birth to a child with fragile
X syndrome. Fertil Steril 2005, 84:1508.
209. Gersak K, Meden-Vrtovec H, Peterlin B: Fragile X premutation in women
with sporadic premature ovarian failure in Slovenia. Hum Reprod 2003,
18:1637–1640.
doi:10.1186/1477-7827-10-97
Cite this article as: Bukovsky and Caudle: Immunoregulation of follicular
renewal, selection, POF, and menopause in vivo, vs. neo-oogenesis
in vitro, POF and ovarian infertility treatment, and a clinical trial.
Reproductive Biology and Endocrinology 2012 10:97.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
